University of Pennsylvania

ScholarlyCommons
Publicly Accessible Penn Dissertations
2012

Molecular Mechanisms of Sleep/Wake Regulation and Memory
Formation in Young and Aged Mice
Mathieu E. Wimmer
University of Pennsylvania, mwimmer@mail.med.upenn.edu

Follow this and additional works at: https://repository.upenn.edu/edissertations
Part of the Molecular Biology Commons, and the Neuroscience and Neurobiology Commons

Recommended Citation
Wimmer, Mathieu E., "Molecular Mechanisms of Sleep/Wake Regulation and Memory Formation in Young
and Aged Mice" (2012). Publicly Accessible Penn Dissertations. 594.
https://repository.upenn.edu/edissertations/594

This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/594
For more information, please contact repository@pobox.upenn.edu.

Molecular Mechanisms of Sleep/Wake Regulation and Memory Formation in
Young and Aged Mice
Abstract
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by deterioration of key physiological processes, including sleep and cognition. Understanding the
mechanisms by which these functions go awry with age is a critical step in identifying novel therapeutic
strategies to improve quality of life for the elderly. One of the most prevalent complaints in the elderly is
the deterioration of sleep/wake patterns, difficulties staying awake and reduced vigilance. Little is known
about the molecular mechanisms controlling these states in the brain. Mouse models are ideally suited to
address this question because they share many similarities with human biology and afford the ability to
manipulate molecular pathways in vivo. In Chapter 2, we use polysomnography and conditional mutant
animals to explore the molecular underpinnings involved in the maintenance of wakefulness. Our results
indicate that the activity-dependent transcription factor cAMP response element binding protein (CREB) is
critical in forebrain neurons for the maintenance of wakefulness. Interestingly, aging also reduces the
ability to sustain wakefulness in the elderly. In Chapter 3, we use polysomnography in young and aged
mice, combined with a novel statistical approach to closely examine how aging impacts the
microstructure of sleep and wakefulness. We show that aging specifically impairs the ability to sustain
long episodes of wake and non-rapid eye movement (NREM) sleep. Another major health concern for
older individuals is the decline of cognitive function. In Chapter 4, we use object-based memory
paradigms to investigate memory formation in aged mice. Object-based tasks are ideally suited for these
studies because they circumvent the confounding alterations in motor function and stress response that
accompany aging. We show that aging impairs the consolidation of memories related to the location of
objects in space. Our findings indicate that the hippocampus, a brain region critical to spatial memory, is
particularly vulnerable to aging. Taken together, our findings outline the molecular pathways involved in
the regulation of sleep and wake and lay the groundwork for further understanding of how these systems
are altered in the aged brain.
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ABSTRACT

MOLECULAR MECHANISMS OF SLEEP/WAKE REGULATION AND
MEMORY FORMATION IN YOUNG AND AGED MICE

Mathieu Eugene Wimmer
Advisor: Ted Abel
Advancements in healthcare and medicine have greatly increased lifespan. Normal
aging is accompanied by deterioration of key physiological processes, including sleep
and cognition. Understanding the mechanisms by which these functions go awry with
age is a critical step in identifying novel therapeutic strategies to improve quality of life
for the elderly. One of the most prevalent complaints in the elderly is the deterioration of
sleep/wake patterns, difficulties staying awake and reduced vigilance. Little is known
about the molecular mechanisms controlling these states in the brain. Mouse models are
ideally suited to address this question because they share many similarities with human
biology and afford the ability to manipulate molecular pathways in vivo. In Chapter 2, we
use polysomnography and conditional mutant animals to explore the molecular
underpinnings involved in the maintenance of wakefulness. Our results indicate that the
activity-dependent transcription factor cAMP response element binding protein (CREB)
is critical in forebrain neurons for the maintenance of wakefulness. Interestingly, aging
also reduces the ability to sustain wakefulness in the elderly. In Chapter 3, we use
polysomnography in young and aged mice, combined with a novel statistical approach to
closely examine how aging impacts the microstructure of sleep and wakefulness. We
v

show that aging specifically impairs the ability to sustain long episodes of wake and nonrapid eye movement (NREM) sleep. Another major health concern for older individuals is
the decline of cognitive function. In Chapter 4, we use object-based memory paradigms
to investigate memory formation in aged mice. Object-based tasks are ideally suited for
these studies because they circumvent the confounding alterations in motor function and
stress response that accompany aging. We show that aging impairs the consolidation of
memories related to the location of objects in space. Our findings indicate that the
hippocampus, a brain region critical to spatial memory, is particularly vulnerable to
aging. Taken together, our findings outline the molecular pathways involved in the
regulation of sleep and wake and lay the groundwork for further understanding of how
these systems are altered in the aged brain.
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Chapter 1. Introduction.
This thesis focuses on the molecular mechanisms controlling the regulation of
sleep/wake states and memory formation and how these processes are altered by aging.
In this Chapter, I will first discuss some of the ways investigators have mapped the
neural circuits that control sleep and wake. I will then provide some background on
cAMP response element binding protein (CREB) family transcription factors and how
CREB signaling relates to memory formation and sleep. Lastly, I will introduce some of
the problems facing the elderly, including the deterioration of sleep/wake patterns and
cognitive decline.
Measuring sleep/wake patterns in the laboratory. Sleep is a highly evolved global
behavioral state and mammals spend anywhere from one-third to one-half of their lives
asleep, depending on the species. Sleep can be defined as a reversible state
characterized by behavioral quiescence and a heightened arousal threshold. Sleep is
not a unitary event. It consists of alternating periods of non-rapid eye movement (NREM)
and rapid eye movement (REM) sleep. These two states can be differentiated using
measures of brain and muscle activity and autonomic functions such as heart rate and
respiration. Polysomnography is the most common method used to measure sleep/wake
and it combines electroencephalography (EEG), the recording of brain activity with
electromyography (EMG), the recording of neck muscle activity (Franken et al., 1991;
Franken et al., 1999; Pace-Schott and Hobson, 2002; Datta and Maclean, 2007). EEG
measures large-scale patterns of activity in the brain with millisecond resolution (Figure
1.1). NREM sleep, which is sometimes referred to as slow wave sleep, is characterized
by high amplitude, low frequency (1-4Hz) waves. The amplitude of these EEG
1

oscillations, referred to as “delta” waves, is indicative of extensive synchrony of neuronal
firing during NREM sleep and this phenomenon is widely used as a marker of sleep
intensity and sleep pressure. Slow wave activity (SWA, the power in the delta 1-4Hz
range during NREM sleep), is highest after periods of extended wakefulness and is
discharged over the course of sleep (Borbely et al., 1981; Borbely, 2001; Franken et al.,
2001). The exact function of these delta waves remains unknown but some evidence
suggests that they are functionally relevant for memory formation (Marshall et al., 2004).
In contrast, waking and REM sleep show high frequency, low amplitude patterns of EEG
activity. One major difference between these two states is that REM sleep is
accompanied by loss of muscle tone (i.e., atonia), which can be visualized using EMG.
Another hallmark of REM sleep, as its name indicates, are rapid eye movements, which
can be detected using electrooculography (EOG). However, EOG recordings are not
required to identify REM sleep and they are not common in the rodent laboratory setting.
Major differences exist between human and rodent sleep. First, mice and rats are
nocturnal and sleep mostly during the light (rest) phase. Secondly, human sleep is more
consolidated and rodents show many more transitions between states, often referred to
as “bouts”. The most consolidated period for rodents occurs during the first ~4 hours of
the dark phase, when animals show extended bouts of wakefulness that can last several
hours. On the other hand, the neurobiology regulating sleep/wake states is similar in
human and rodents and much has been learned about how the brain controls these
states using animal models.

Neurobiological mechanisms controlling sleep/wake behavior. Mapping of the
neural circuits that control wakefulness and sleep began nearly 100 years ago when the
2

neurologist Constantine Von Economo described a series of unusual cases of
Encephalitis Lethargica (EL) after World War I in the journal Wiener Klinische
Wochenschrift (1917). Von Economo identified 3 distinct clinical patterns of EL: 1) the
somnolent-opthalmoplegic EL caused extreme sleepiness followed by coma and often
death, 2) the hyperkinetic form was characterized by insomnia and restlessness and 3)
the amyostatic-akinetic appeared to be related to Parkinsonism, with weakness, rigidity
and bradykinesia. Post-mortem, Von Economo carefully studied the location of lesions
in these patients and outlined which brain regions were likely to be critical for the
regulation of sleep and wakefulness. Based on his histopathological observations, Von
Economo defined the preoptic area as important for sleep, as lesions to this “sleep” area
caused insomnia. In contrast lesions to the posterior hypothalamus (“waking” region)
induced sleep and heightened arousal thresholds. Von Economo’s original observations
have been refined over time and much has been learned in the past 60 years about the
specific systems that influence sleep/wake. Recent electrophysiological and behavioral
studies have led to an improved understanding of the neurochemicals, pathways, and
cell firing patterns that regulate these states. The “waking” and “sleep” regions are
composed of complex mutually inhibitory networks of neurons that integrate circadian
and homeostatic inputs to produce sleep/wake patterns (Datta and Maclean, 2007).
Activation of the wake-promoting system in the brain produces arousal and inhibits the
initiation of sleep. The state of wakefulness is a complex coordinated expression of
behaviors that are regulated by many neurochemically defined cells groups: 1)
noradrenergic neurons in the locus Coereleus (LC), 2) orexinergic (hypocretin) cells in
the lateral hypothalamus (LH) 3) serotonergic (5-HT) cells in the raphe nuclei (RN), 4)
cholinergic (Ach) neurons in the pedunculopontine tegmentum (PPT), 5) dopaminergic
3

(DA) cells in the substantia nigra compacta (SNc) and ventral tegmental area (VTA), 6)
cholinergic and glutamatergic neurons of the basal forebrain (BF). Projections from
these pontine and midbrain wake-promoting cells travel dorsally to activate
thalamocortical pathways as well as ventrally to activate hypothalamo-cortical and
basalo-cortical systems (Garcia-Rill et al., 2004; Skinner et al., 2004; Morgane et al.,
2005).
LC noradrenergic neurons have long been associated with arousal and attention. LC
cells fire maximally during wake and LC firing precedes the onset of wakefulness (AstonJones and Bloom, 1981; Foote et al., 1983; Takahashi et al., 2010), suggesting that
these neurons are critical for the initiation of wakefulness, particularly out of NREM sleep
(Takahashi et al., 2010). LC projects directly to the cortex and maximum levels of
spontaneously released norepinephrine (NE) in the forebrain and cerebral cortex occur
during wake (Florin-Lechner et al., 1996; Berridge and Abercrombie, 1999). In addition,
direct activation of LC produces arousal and EEG de-synchronization consistent with
wakefulness (Berridge and Foote, 1991; Berridge et al., 1993; Berridge and Foote,
1996).
Orexin/hypocretin neurons, which are localized to the LH (de Lecea et al., 1998; Peyron
et al., 1998), project directly to cerebral cortex and broadly throughout the brain.
Importantly, orexin cells heavily innervate many of the wake promoting brain regions,
including the PPT, LC, RN, SNc, and VTA (Peyron et al., 1998; Nambu et al., 1999;
Taheri et al., 1999) and application of orexin to these areas is excitatory (Hagan et al.,
1999; Bourgin et al., 2000; Takahashi et al., 2002). Orexin cells are more active during
wakefulness than during sleep (Alam et al., 2002; Koyama et al., 2003) and extracellular
levels of orexin are highest during wake (Kiyashchenko et al., 2002; Zeitzer et al., 2003).
4

Thus, orexin signaling is thought to be important for the maintenance of wakefulness.
Consistent with this hypothesis, ablation and genetic deletion of orexin cells or orexin
receptors causes narcolepsy and stimulation of orexin neurons produces wakefulness
(Chemelli et al., 1999; Hara et al., 2001; Adamantidis et al., 2007).
5-HT neurons of the RN project to the forebrain and cerebral cortex (Consolazione et al.,
1981; Tork, 1990) and fire maximally during wakefulness (Lydic et al., 1983). The
literature regarding the role of these neurons in the regulation of sleep/wake is mixed,
with some reports suggesting that 5-HT promotes sleep (Petitjean et al., 1978; Datta et
al., 1987; Cape and Jones, 1998) and other studies indicating that 5-HT is important for
the maintenance of wakefulness (Monti and Jantos, 1992; Ponzoni et al., 1993; Boutrel
et al., 2002). Thus, serotonergic cells in the RN may be involved in the regulation of both
wakefulness and NREM sleep via processes that remain to be elucidated.
Single unit recordings from Ach PPT neurons across sleep/wake revealed the presence
of at least 4 cell types: 1) REM-on, 2) Wake-REM-on, 3) Wake-on and 4) sleep-wake
unrelated (Saito et al., 1977; el Mansari et al., 1990; Steriade et al., 1990; Datta, 1995).
These findings suggest that the PPT is involved in promoting both wakefulness and
REM sleep. Consistent with this interpretation, stimulation of PPT induces wakefulness
and REM sleep (Datta and Siwek, 1997; Datta et al., 2001). Cholinergic cells of the PPT
do not directly project to cerebral cortex (Datta, 1995), but stimulation of PPT promotes
wakefulness by activating thalamo-cortical, hypothalamo-cortical and basalo-cortical
pathways (Datta, 1997).
DA neurons located in the SNc and VTA heavily innervate the frontal cortex and basal
forebrain (Hillarp et al., 1966; Freeman et al., 2001; Jones, 2005), where extracellular
5

levels of DA are highest during wake states (Trulson, 1985; Smith et al., 1992; Feenstra
et al., 2000). In addition, injection of dopamine receptor agonists induces wakefulness at
the expense of NREM and REM sleep (Monti et al., 1990; Isaac and Berridge, 2003).
Conversely, dopamine antagonist injections and genetic deletion of D2 dopamine
receptors reduce wakefulness (Monti et al., 1990; Trampus et al., 1991; Qu et al., 2010).
Thus, besides their well established role in driving motivated behaviors (Grace et al.,
1998), dopaminergic cells are also an important component of the wake promoting
system.
The BF contains cholinergic and glutamatergic neurons that can activate cortical
pyramidal cells either directly or indirectly, causing EEG desynchronization (Jones,
2004). Many of the BF neurons are most active during wake and their activity pattern
matches with specific EEG rhythms. Consistent with these observations, lesions of the
BF either result in slowing of the EEG or in reduced levels of wakefulness (Kaur et al.,
2008). Acute manipulations inhibiting or activating BF produce NREM sleep and
wakefulness, respectively (Cape and Jones, 2000).
Opposing the arousal system, is a group of inhibitory neurons in the ventrolateral
preoptic area (VLPO), that send projections to wake promoting nuclei (Sherin et al.,
1998). VLPO also receives inputs from the arousal system and VLPO neurons are
inhibited by NE, 5-HT, DA and Ach (Gallopin et al., 2000; Gallopin et al., 2004). Firing of
VLPO cells is highest during sleep, with some neurons firing preferentially prior to the
onset of and during NREM sleep and other sub-populations firing preferentially at the
onset and during REM sleep (Takahashi et al., 2009). Furthermore, lesions to VLPO
reduces NREM and REM sleep by about 50% (Lu et al., 2000; Lu et al., 2006), indicating
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that other regions in the brain are also required for promoting sleep. Some of these cells
are located in the pons and are known to drive REM sleep (Datta, 1995).
Current models of sleep/wake regulation postulate that interactions between wake- and
sleep-promoting systems can be modeled as a “flip-flop” switch, where transitions
between states are rapid and dependent upon one side overpowering the other (Saper,
2006; Saper et al., 2011). Thus, firing of cortical neurons is controlled by the flip-flop
switch with homeostatic and circadian influences (Borbely, 1982), and these systems
ultimately dictate the behavioral state of the animal. The work described in Chapter 2,
explores the molecular mechanisms within the FB and the LC that are involved in the
maintenance of wakefulness. Experiments in Chapter 3 examine how aging impacts the
regulation of sleep/wake states and which nuclei in the brain are likely to be altered in
the aged brain.

The function and regulation of cAMP response element binding protein (CREB)
family transcription factors. Several vital functions in mammals require the ability of
cells to properly communicate with their environment. The conversion of extracellular
stimuli into signals promoting cell growth, survival or death is largely orchestrated by
changes in gene expression. In the brain, these processes not only regulate
development in early life, but also continue to mold the connections between neurons
that are at the root of many essential behaviors and physiological processes in the
mature nervous system. Extensive studies of the CREB family of transcription factors
have revealed that signaling cascades involving CREB-related proteins are key

7

mediators of activity-dependent nuclear responses underlying development, proper
function and plasticity of the nervous system.
CREB belongs to the basic leucine zipper (bZIP) family of transcription factors, which
includes the closely related transcription factors cAMP response element modulator
(CREM), and activating transcription factor 1 (ATF-1). The bZIP domain facilitates
homo-dimerization and hetero-dimerization of CREB family transcription factors, a
requirement for DNA binding to cAMP response element (CRE) sites (TGACGTCA).
CRE sites are found within the regulatory region of numerous genes, many of which are
subject to regulation by CREB. CREB-mediated transcription is activated in response to
a vast array of physiological stimuli, which are transduced through a variety of signaling
cascades.
One of the best studied mechanisms activating CREB-mediated transcription is the
phosphorylation of CREB at serine-133 (pCREB), which promotes the recruitment of coactivators such as CREB binding protein (CBP) and the interaction with the
transcriptional machinery. This serine residue of CREB can be phosphorylated by the
cAMP/PKA pathway, calcium signaling and Ca2+ calmodulin kinases (CaM kinases), as
well as the mitogen activated protein kinase (MAPK) pathway (Gonzalez and Montminy,
1989; Dash et al., 1991; Sheng et al., 1991; Xing et al., 1996; De Cesare et al., 1998;
Deak et al., 1998; Xing et al., 1998). CREB-mediated transcription can also be induced
through phosphorylation-independent mechanisms. CREB-regulated transcription
coactivator (CRTCs) interact with the bZIP domain of CREB and can influence
transcription (Conkright et al., 2003; Takemori et al., 2007; Xu et al., 2007). CRTCCREB interaction requires phosphorylation of CRTC by salt inducible kinase (SIK) and
shuttling of CRTC to the nucleus. It is thought that these many layers of regulation
8

permit the broadly expressed CREB transcription factor to serve such a wide array of
functions in different cell types.
Researchers have developed extensive genetic tools to experimentally alter and
manipulate CREB signaling and CREB-mediated gene transcription. Constitutive and
conditional knock out of CREB have been widely used to study CREB function in the
nervous system (Hummler et al., 1994; Mantamadiotis et al., 2002). Another example is
the dominant-negative form of CREB CREBM1 (mCREB), where serine 133 has been
replaced by an alanine residue. This mutation prevents phosphorylation without
interfering with the ability of mCREB to dimerize with endogenous CREB family
transcription factors, or with the ability of dimers to bind DNA (Gonzalez and Montminy,
1989; Chrivia et al., 1993; Kwok et al., 1994). Thus mCREB reduces transcription of
CREB target genes by interfering with recruitment of co-activators and transcriptional
machinery. KCREB is another dominant-negative mutant form of CREB, which harbors a
point mutation in the DNA-binding domain. Thus, KCREB reduces gene expression by
titrating wild-type CREB and interfering with DNA binding (Pittenger et al., 2002). In
contrast, constitutively active forms of CREB, such as CREB-VP16, have also been
engineered. This mutant form of CREB can heterodimerize with endogenous CREB
proteins and activate transcription in the absence of serine 133 phosphorylation (Barco
et al., 2002). These molecular tools have led to a vastly improved understanding of both
the regulation and the functions of CREB signaling.
CREB is best known for its involvement in memory formation and synaptic plasticity.
Studies in Aplysia (sea slug), Drosophila (fruit fly) and rodents indicate that CREB is
required for long-term memory consolidation (Kaang et al., 1993; Bourtchuladze et al.,
1994; Kwok et al., 1994; Yin et al., 1994; Graves et al., 2002), the process by which
9

labile short-term memories are stabilized into long-term traces. Presumably, CREB
signaling facilitates memory formation through the induction of synaptic plasticity
(Bourtchuladze et al., 1994; Cha-Molstad et al., 2004; Marie et al., 2005), although the
exact mechanisms underlying the ability of CREB to promote memory formation are not
completely understood. CREB function is likely important in the hippocampus and in the
amygdala to support memory formation. In other brain regions, such as the LC, striatum,
and the VTA, CREB activity has been linked to reward and the development of drug
addiction (Barrot et al., 2002; Walters et al., 2003; Carlezon et al., 2005; Parlato et al.,
2010). Another important role of CREB is in the development of depression and anxiety
(Chen et al., 2001; Barrot et al., 2002). The experiments described in Chapter 2 build
upon the literature suggesting that CREB signaling is also involved in the maintenance
of wakefulness. These studies are aimed at uncovering where in brain CREB is required
for the regulation of sleep and wakefulness.

Aging, sleep and memory formation. Improvements in healthcare have greatly
increased life expectancy worldwide. Within the US alone, it is estimated that 20% of the
population will be over the age of 65 years by 2030 (Kinsella, 2001). By 2050, older
adults will likely outnumber children under age 15 (Cohen, 2003). Importantly, normal
aging is accompanied by deterioration of key physiological processes including
cognition, motor behavior, stress response and sleep. Given the growing senior
population, understanding the mechanisms by which these functions go awry with age is
a critical step in identifying novel therapeutic strategies and to increase quality of life for
the elderly.

10

One of the most significant problems facing older individuals is the deterioration of
sleep/wake patterns. Aged individuals report difficulties falling and staying asleep, as
well as early awakenings. These changes during the night are also accompanied by
increased napping and sleepiness during the day (Dijk et al., 1989; Ehlers and Kupfer,
1989; Bliwise, 1993; Prinz, 1995; Landolt et al., 1996; Dijk et al., 2000). In Chapter 3, we
explore age-related changes in sleep and wakefulness in mice using a novel statistical
approach designed to detect small changes in the organization of sleep and wake
states.
The deterioration of memory formation is another major concern for the elderly
population. Memory is one of the earliest cognitive functions to show decline during
normal aging. Age-associated memory impairment (AAMI), a condition that excludes all
other causes (i.e. neurodegenerative diseases) other than aging, is prevalent (over 40%)
(Larrabee and Crook, 1994). Episodic memory, a type of declarative memory that
depends on the ability to remember facts in a determined temporal and spatial context,
is especially vulnerable to normal aging (McIntyre and Craik, 1987). Related to episodic
memory, spatial memory and spatial navigation are also particularly sensitive to the
deleterious effects of aging. Both types of memories require the hippocampus and
evidence from the past 20 years suggest that altered hippocampal function is a key
component of age-related memory decline (Miller and O'Callaghan, 2005). Early reports
suggested that cell loss was to blame for cognitive decline. However, recent work
indicates that alterations of intracellular signaling pathways and synaptic connections
cause memory decline with age. Many of the processes involved in memory formation
are altered by aging in the brain. Calcium buffering as well as the activity of CaM
kinases, PKA and CREB change with age (Foster et al., 2001; Karege et al., 2001a;
11

Karege et al., 2001b; Countryman and Gold, 2007; Toescu, 2007; Toescu and
Vreugdenhil, 2010). In Chapter 4, we use object-based tasks to investigate the effects of
aging on memories that require hippocampal function.
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Figure 1.1. EEG and EMG recordings from mice. Typical polygraphic appearance of
wakefulness (top), NREM sleep (middle) and REM sleep (bottom panel) in the adult
mouse. During wakefulness, cortical EEG presents de-synchronized low amplitude,
high-frequency waves, a sign of cortical activation and EMG tone. NREM sleep is
characterized by high-amplitude, low frequency waves with muscle tone still present, but
reduced compared to wakefulness. During REM sleep, cortical EEG is activated similarly
to wake EEG but EMG show marked reduction or absence of muscle tone (atonia).

Figure 1.2 Activation of CREB signaling via phosphorylation of Serine 133.
Calcium (Ca2+) binds calmodulin (CaM) protein and Ca2+/CaM activates CaM kinase IV
(CaMKIV), a part of the calcium calmodulin kinase (CaMK) cascade. Upon activation,
nuclear CaMKIV phosphorylates CREB induces gene transcription. Ca2+ signaling also
leads to CREB phosphorylation by activation of the MAPK/ERK pathway. G protein
coupled receptors activate adenylyl cyclase, increasing cAMP levels, which results in
PKA-mediated phosphorylation of CREB.
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Chapter 2. CREB is Required in Forebrain Neurons to
Sustain Wakefulness
Abstract
Although our understanding of sleep/wake regulation at the systems level has advanced
over the past 50 years, little is known about the molecular and intracellular signaling
processes that control sleep/wake states. A consistent observation is that the cyclicAMP response element binding protein (CREB), an activity-dependent transcription
factor, is differentially activated during sleep and wakefulness. CREB is phosphorylated
by the cyclic AMP/protein kinase A (cAMP/PKA) signaling pathway as well as other
kinases and phosphorylated CREB (pCREB) promotes transcription of target genes.
Genetic studies in flies and mice suggest that CREB signaling influences sleep/wake
states by promoting and stabilizing wakefulness. However, it remains unclear where in
the brain CREB is required to drive wakefulness. In rats, CREB phosphorylation
increases in the cerebral cortex during wakefulness and decreases during sleep, but it is
unclear whether this change is functionally relevant to the maintenance of wakefulness
or the drive to sleep. Here, we used the cre/lox system to conditionally delete CREB in
the Locus Coereleus (LC) and in the forebrain, two regions known to be important
arousal and wakefulness. We used polysomnography to measure sleep/wake levels and
architecture in conditional CREB mutant mice and control littermates. We found that
forebrain-specific deletion of CREB decreased wakefulness and increased non-rapid eye
movement (NREM) sleep. In addition, mice lacking CREB in the forebrain were unable
sustain normal periods of wakefulness. Forebrain specific CREB conditional knock out
mice showed similar sleep rebound following a brief period of sleep deprivation. On the
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other hand, deletion of CREB from LC neurons did not change sleep/wake levels or
sleep/wake microstructure. Taken together, these results suggest that CREB is required
in neurons within the forebrain to promote and stabilize wakefulness.

Introduction
Mapping of the neural circuits that control wakefulness and sleep began over 50 years
ago and much has been learned in the past 10-20 years about the specific systems that
influence sleep/wake. Recent electrophysiological and behavioral studies have led to an
improved understanding of the neurochemicals, pathways, and cell firing patterns that
regulate these states. Wake promoting regions such as the locus Coereleus (LC) (AstonJones and Bloom, 1981) send projections to the cerebral cortex and activity in these
regions produces EEG de-synchronization consistent with arousal and wakefulness
(Berridge and Foote, 1991). This arousal producing system is balanced by sleeppromoting areas, which induce sleep and suppress wakefulness (Lu et al., 2000). These
two mutually inhibiting systems act in concert with circadian and homeostatic processes
to regulate sleep/wake states. However, little is known about the intracellular processes
underlying sleep/wake regulation. Genetic and imaging studies have identified the CREB
signaling pathway and CREB-regulated transcription as potential mechanisms of
sleep/wake regulation. It is well established that the CREB transduction pathway is
involved in synaptic plasticity and memory formation (Silva et al., 1998; Abel and Lattal,
2001; Lonze and Ginty, 2002; Carlezon et al., 2005; Alberini, 2009; Benito and Barco,
2010; Josselyn, 2010). CREB signaling is also essential to the proper regulation of
sleep/wake states. Mice lacking two isoforms of CREB show reduced wakefulness and
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increased sleep (Graves et al., 2003b). In flies, CREB activity is inversely related to rest
(Hendricks et al., 2001). However, it is unclear where in the brain CREB plays a critical
role to sustain wakefulness. CREB activity and expression of CREB downstream target
genes are increased in the cortex following periods of wakefulness (Cirelli and Tononi,
2000). These changes in the cortex require inputs from the LC (Cirelli et al., 1996) and
mice lacking dopamine beta hydroxylase (DBH), the enzyme required for norepinephrine
synthesis, show reduced wakefulness and wake fragmentation (Ouyang et al., 2004).
Taken together, these studies suggest that CREB may be required in the cortex and/or
in the LC to promote and stabilize wakefulness. We used conditional knock out
approaches to determine where CREB is required to sustain wakefulness.

Methods
Animals. Forebrain CREB cKO (FB CREB cKO) mice were obtained by crossing
animals expressing Cre recombinase driven by the CaMKIIα promoter (Dragatsis and
Zeitlin, 2000) to mice carrying a floxed allele of Creb1 (Mantamadiotis et al., 2002). Mice
lacking CREB in noradrenergic neurons were obtained by crossing mice expressing cre
recombinase driven by the dopamine beta hydroxylase (DBH) promoter (Parlato et al.,
2010) to mice carrying a floxed allele of Creb1 (Mantamadiotis et al., 2002). All lines
were backcrossed to C57Bl/6J. Experimental CREB conditional knock out animals were
male and female mice homozygous for the floxed Creb1 allele and hemizygous for the
cre transgene. Control mice were either hemizygous for cre recombinase or carried
floxed alleles of Creb1. Animals were maintained on a 12 hour light/12 hour dark cycle
with lights on (ZT 0) at 7:00 am. Food and water were available ad libitum. All animal
18

care and experiments were approved by the Institutional Animal Care and Use
Committee of the University of Pennsylvania and conducted in accordance with the
National Institute of Health guidelines.

Surgery. Animals were implanted with EEG and EMG electrodes under isoflurane
anesthesia. Electrodes were held in place with dental cement (Ketac, 3M, St Paul, MN).
Electrodes consisted of Teflon coated wires (Cooner wires, Chatsworth, CA) soldered to
gold socket contacts (Plastics One, Roanoke, VA) and pushed into a 6-pin plastic plug
(363 plug, Plastics One). The contacts were cemented to the plug using dental cement.
Animals were connected to amplifiers using light-weight cables (363, Plastics One)
attached to a rotating commutator (SLC6, Plastics One). All recordings were obtained
using a parietal electrode (ML ±1.5mm from Bregma, AP +2mm from Lambda)
referenced to an electrode over the cerebellum (1.5 mm posterior of Lambda). Mice
were allowed to recover from surgery for a minimum of 2 weeks. During the second
week of recovery, mice were acclimated to the cables and to the recording chambers.

EEG recordings and analysis. EEG/EMG signals were recorded over a 24-hour
baseline period, during which animals were undisturbed. The next day, animals were
sleep deprived (SD) for 6 hours, starting at lights on (ZT 0) using gentle handling
(Vecsey et al., 2009) and allowed to recover for 18 hours. EEG/EMG signals were
sampled at 256 Hertz (Hz) and filtered at 0.5-30Hz and 1-100Hz, respectively with 12A5
amplifiers (Astro-Med, West Warwick, RI). Data acquisition and visual scoring was
performed using SleepSign software (Kissei Comtec, INC, Japan). EEG/EMG recordings
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were scored in 4 second epochs as wake, NREM, or REM by a trained experimenter
blind to genotype. Epochs containing movement artifacts were included in the state
totals and architecture analysis, but excluded from subsequent spectral analysis.
Spectral analysis was performed using a fast Fourier transform (FFT; 0.5-20Hz, 0.125Hz
resolution). EEG spectra were computed over 24 hours. NREM EEG spectra were also
computed in 2 hour windows for the baseline and SD periods. NREM slow wave activity
(SWA), was normalized to the last 4 hours of the light phase of the baseline day for each
animal as previously described (Franken et al., 2001).

Immunohistochemistry. Mice were anesthetized with isoflurane and transcardially
perfused with ice cold PBS, followed by ice cold 4.0% paraformadelhyde using a
peristaltic perfusion pump (Rainin Instruments, Oaklan, CA). Fixed brains were
dissected, postfixed overnight and cryoprotected in 30% sucrose. Brains were frozen
and cryosectioned coronally at a thickness of 30 um into PBS. Floating sections were
blocked for 1 hour at room temperature in 2% normal donkey serum (NDS, Vector
Laboratories, Burlingame, CA) in 0.3% Triton X-100 PBS. Sections were first processed
for CREB-immunostaining with nickel ammonium sulfate intensification of DAB and then
processed for tyrosine hydroxylase (TH). Sections were incubated overnight at 4C in 2%
NDS, 0.1% Titon X-100 in PBS with anti-CREB primary antibody (1:3,000; 9197 Cell
Signaling, Danvers, MA), 2 hours at room temperature with biotynalated donkey antiRabbit secondary antibody in 0.1% Triton X-100 PBS (1: 500; Jacskon Immunoresearch,
Newmarket Suffolk, England) and 1.5 hours at room temperature with ABC in 0.1%
Triton X-100 (1:500; Vector Laboratories, Burlingame, CA). Sections were washed 3 x
10 minutes with PBS between each incubation. The same procedure was followed for
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TH immunostains using anti-TH antibody (1:10,0000, Millipore, Billerica, MA). For
fluorescent immunohistochemistry, FITC-conjugated anti-rabbit IgG secondary antibodie
(1:1000, Chemicon, Temecula, CA) were used. Sections were mounted on slides and
imaged using a microscope or confocal microscope. Cell counting and optical density
measurements were conducted using ImageJ. 6 sections (3 from each side) from 3-4
animals were used for all quantifications of CREB levels.
Quantitative real-time PCR. Cortex samples were collected into 500 uL of RNAlater
(Ambion, Austin, TX) at ZT16 and flash frozen. All collections were done under red light
to avoid any potential light pulse effects. The list of transcripts examined was based on
previous reports showing that CREB is required for the expression of these genes
(Lemberger et al., 2008). Preparation of mRNA and cDNA synthesis were conducted as
previously described (Vecsey et al., 2007). PCR reactions were prepared in 96-well
optical reaction plates (Applied Biosystems, Foster City, CA). Each well contained 10 uL
of cDNA and 1uL of of Taqman probes and 9 uL of Taqman Fast Universal PCR Master
Mix (Applied Biosystems, Foster City, CA). 6 biological and 3 technical replicates were
used. Data were normalized to Hprt1 (probe ID Mm0145399-m1, Tuba4a
(Mm00849767-S1) and Gapdh (Mm99999915_g1). Fold change was calculated from the
ΔCt cycle threshold values with corrections for standard curve data from each gene and
housekeeping gene expression levels for each sample. For each sample, ΔCt was
calculated against the mean for the sample set of that gene. Next, each of these values
was corrected with the slope of the standard curve for the relevant probe to account for
efficiency. This corrected value was normalized to the ΔCt from housekeeping genes for
each sample to account for input variability. Fold change is equal to two raised to the

21

difference between experimental and control Ct values. Student’s t-tests were used to
compare groups.

Statistics. Student’s t-tests were used to compare wake, NREM and REM sleep levels
averaged over 24 hours. Multivariate analysis of variance (MANOVA) was used on the
proportion of time spent in each state during the light phase, the dark phase and during
the 8 x 3-hour time points across 24 hours, followed by Tukey studentized range tests to
compare genotype groups. The same procedure was applied to the number of bouts and
the average bout duration to compare groups. MANOVA was also used to compare the
difference in total sleep time, NREM and REM sleep between the baseline and recovery
periods following 6 hours of SD. Tukey studentized range tests were used to analyze
raw EEG spectra for wake, NREM and REM sleep. Student’s t-tests were used to
analyze theta peak frequency for wake and REM EEG spectra. NREM SWA during the 4
x 2-hour bins was analyzed using repeated measures ANOVA followed by Tukey
studentized range tests.

Results
CREB is required in the forebrain to sustain wakefulness. Forebrain CREB
conditional knock out mice (FB CREB cKO) were generated by crossing a Creexpressing line driven by the CaMKIIα promoter (Dragatsis and Zeitlin, 2000) to animals
carrying a floxed allele of Creb1 (Mantamadiotis et al., 2002) (Figure 2.1A). We
quantified levels of CREB using optical density measurements of sections immunostained for CREB. CREB protein levels were reduced by 66% in FB CREB cKO
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(p=0.005, Figure 2.1B-F). Expression of Creb1 was markedly reduced in the cortex of FB
CREB cKO animals (Table 2.1). Expression of CREB target genes Nr4a1 and Gadd45b
were also decreased. In contrast, expression of cAMP response element modulator
(CREM), another member of the same family of transcription factors was increased in
conditional CREB mutant animals (Table 2.1), consistent with results in other CREB
mutant models. We used EEG/EMG recordings to measure wake, non-rapid eye
movement (NREM) and rapid eye movement (REM) sleep in conditional CREB mutant
animals and control littermates. During the 24 h baseline period, animals were
undisturbed and recording began at lights on (ZT0). FB CREB cKO animals showed
decreased wakefulness over 24 hours (F(2,45)=11.39, p<0.0001) and during both the
light and the dark periods (Figure 2.2A , F(4,88)=6.32, p=0.0002). Decreased
wakefulness was accompanied by increased NREM sleep in FB CREB cKO compared
to control (F(2,45)=11.18, p<0.0001) over 24 hours and during the light and dark periods
(Figure 2.2B, F(4,88)=6.09,p=0.0002). REM sleep levels were unchanged over 24 hours
(F(2,45)=2.59, p=0.09). However, REM levels increased in FB CREB cKO animals
during the dark phase (Figure 2.2C, F(4,88)=2.58, p=0.04). Multivariate analysis of
variance (MANOVA) revealed that FB CREB cKO animals have decreased wakefulness
across the light/dark cycle (Figure 2.2D, F(16,76)=2.71, p =0.0.0019). We used Dunnett
post-hoc comparisons to compare groups in 3 hour bins across the day (Figure 2.2 D-F)
and found that the effect of genotype on wakefulness differs across time (Figure 2.2D).
NREM sleep was also increased at several time points in FC CREB cKO animals (Figure
2.2E, F(16,76)=2.66, p=0.0023). REM sleep was only increased in FB CREB cKO during
the active (dark) period (Figure 2.2F, F(16,76)=2.19, p=0.0123). These results suggest
that CREB is required in the forebrain for appropriate levels of wakefulness.
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CREB is required in the forebrain to sustain wakefulness. To determine the nature
of the reduction in wakefulness, we examined the architecture or wake, NREM and REM
sleep by computing the number of bouts and the average duration of these events in
each state. FB CREB cKO mice showed an increased number of wake bouts during the
light and dark phase (Figure 2.3A, F(4,86)=10.64,p<0.0001). In addition, the average
duration of wake bouts was reduced in FB CREB cKO mice (Figure 2.3B, F(4,86)=13.74,
p<0.0001). The number of NREM bouts increased in FB CREB cKO (Figure 2.3C,
F(4,86)=4.37, p=0.0029). However, the average duration of NREM bouts was reduced
only for Cre expressing control animals during the light phase (Figure 2.3D,
F(4,86)=4.61, p=0.0020). The number of REM bouts was similar in all 3 groups (Figure
2.3E, F(4,86)=2.5, p=0.05) and REM bout duration was reduced in FB CREB cKO during
the light phase (Figure 2.3F, F(4,86)=5.55, p=0.0005). Taken together, these results
suggest that CREB is required in the forebrain to sustain wakefulness.

Deletion of CREB in the forebrain does not increase sleep homeostasis. Following
the baseline day, animals were sleep deprived for 6 hours using gentle handling (Graves
et al., 2003a; Graves et al., 2003b; Vecsey et al., 2009) starting at lights on and mice
were allowed to recover for the subsequent 18 hours. FB CREB cKO animals showed
similar total sleep rebound following sleep deprivation when compared to wild-type
littermates (Figure 2.4A, F(8,9)=1.81, p=0.1966). NREM sleep (Figure 2.4B, F(8,9)=1.67,
p=0.2310) and REM sleep (Figure 2.4C, F(8,9)=0.55, p=0.7973) also increased similarly
in both groups during the recovery period (ZT 6-24). Slow wave activity (SWA), the
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power in the delta (0.5-4Hz) frequency range during NREM sleep is a marker of sleep
pressure and sleep intensity (Borbely et al., 1981; Borbely, 1982; Franken et al., 2001).
SWA was normalized to the last 4 hours of the light phase during the baseline period for
each animal (Franken et al., 2001; Halassa et al., 2009; Hasan et al., 2010). During the
baseline period, SWA was highest at lights on and decreased over the course of the light
phase (Figure 2.4D, time: F(3,54)=48.78, p<0.001). FB CREB cKO showed reduced
SWA during the baseline day (time by genotype interaction: F(3,54)=4.46, p=0.0251).
Following sleep deprivation, SWA was highest when the animals were allowed to sleep
(ZT 6) and decreased during recovery sleep (Figure 2.4E, time: F(3,54)=134.38,
p<0.0001). SWA was lower for FB CREB cKO (time by genotype interaction:
F(3,54)=9.62, p=0.0002). These results indicate that, in forebrain neurons, CREB is not
directly involved in the accumulation of sleep pressure and that CREB does not serve a
restorative function during sleep.

Deletion of CREB from forebrain neurons does not change EEG spectral content.
We examined EEG spectral content using fast Fourier transform (FFT) of wake (Figure
2.5A and B), NREM (Figure 2.5C and D) and REM sleep (Figure 2.5 E and F). In
particular, we quantified power in the theta (6-10Hz) range during wakefulness, a marker
of arousal as well as power in the delta range during NREM sleep, an indicator of sleep
pressure. We found no difference in absolute theta power during wake (Figure 2.5G,
F(2,42)=0.58, p=0.5646) or REM sleep (F(2,42)=0.79, p=0.4596). Delta power during
NREM was also similar in all 3 groups (F(2,42)=0.69, p=0.5063). Because electrode
placement can impact absolute power density, we also normalized each of these values
to the overall average power for each animal. This normalization had no effect on theta
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power during wake (Figure 2.5H, F(2,42)=2.39, p=0.1037) or delta power (F(2,42)=0.05,
p=0.9510). Theta power during REM sleep was lower in Cre expressing controls
compared to wild-type (F(2,42)=7.44, p=0.0017). A separate cohort of animals was used
to examine circadian activity patterns in FB CREB cKO (n=6) and control (n=8) animals.
Mice showed rhythmic activity patterns under 12h-12h light/dark conditions and under
constant darkness. Deletion of CREB did not affect the period (control Tau=23.54±0.04;
cKO Tau=23.64±0.08; p=0.202).

CREB is not required in the LC to sustain wakefulness. In the next set of
experiments, we investigated whether LC CREB signaling is required to sustain
wakefulness in the LC, a brain area known to be critically involved in arousal and
vigilance. We used the DBH promoter (Parlato et al., 2010) to confer deletion of CREB
to noradrenergic neurons (LC CREB cKO, Figure 2.6A). LC CREB cKO mice showed
reduced expression of CREB in neurons that were positive for tyrosine hydroxylase (TH)
in the LC (Figure 2.6B, C and D, 86% reduction, p=1.19 x 10-5). LC CREB cKO mice
showed similar levels of wake compared to wild-type littermates over 24 hours
(p=0.4930) and during the light and dark phase (Figure 2.7A, F(2,14)=0.25, p=0.7803).
NREM levels were also similar for both groups over 24 hours (p=0.4397) and during the
light and dark phase (Figure 2.7B, F(2,14)=0.31, p=0.7383). REM sleep was also
unchanged by deletion of CREB in LC neurons (Figure 2.7C, 24 hours, p=0.9837,
light/dark F(2,14)=0.01, p=0.9950). LC CREB cKO showed similar levels of wake, NREM
and REM sleep at each 3 hour time point across the light/dark cycle (wake: Figure 2.7D
F(8,8)=1.30, p=0.3602, NREM: Figure 2.7E, F(8,8)=1.68, p=0.2386, REM: Figure 2.7F,
F(8,8)=0.43, p=0.8702). Deletion of CREB from LC did not affect the number of bouts for
26

wake (Figure 2.8A, F(2,14)=0.42, p=0.6646), NREM (F(2,14)=0.29, p=07554) and REM
sleep (F(2,14)=0.42, p=0.6630). The average duration for wake, NREM and REM sleep
was similar in LC CREB cKO compared to wild-type littermates (Figure 2.8B, wake:
F(2,14)=0.20, p=0.8208, NREM: F(2,14)=0.08, p=0.9211, REM: F(2,14)=1.23,
p=0.3255). These results indicate that CREB is not required in the LC to promote
wakefulness.

Discussion
The goal of this study was to identify where in the brain CREB is important for the
induction and maintenance of wakefulness. The LC is a critical component of the arousal
system and activity in noradrenergic neurons can desynchronize cortical EEG and
produce arousal (Aston-Jones and Bloom, 1981; Berridge and Foote, 1991; Berridge et
al., 1996; Berridge and Foote, 1996). Wake promoting regions share the cerebral cortex
as a common output and cortical activity ultimately dictates behavioral state (Saper,
2006; Datta and Maclean, 2007). We used conditional knock out approaches to
separately test the role of CREB in these two components of the neural-circuitry known
to control wakefulness.

Our results reveal that CREB is required in forebrain neurons but not in the LC to sustain
wakefulness. The reductions in wake that we observed in FB CREB cKO mice were due
to the inability of these animals to sustain normal periods of wakefulness. Interestingly,
CREB deficiency only destabilized wakefulness, sparing NREM and REM sleep
architecture. The number of NREM sleep episodes increased, while the average
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duration of NREM bouts was unchanged in the CREB mutants. Taken together, these
results indicate that CREB is critical in forebrain neurons to sustain extended periods of
wakefulness.

We used sleep deprivation experiments to test the possibility that reduced and
fragmented wakefulness resulted from increased sleep pressure. Chronic heightened
sleep pressure is characterized by enhanced sleep homeostatic responses as shown in
chronic sleep restriction experiments (Leemburg et al., 2010) or in animal models with
genetic manipulations resulting in increased sleep homeostasis (Naylor et al., 2000;
Hendricks et al., 2001; Frank et al., 2002). In contrast, FB CREB cKO mice showed
normal amounts of sleep rebound following brief sleep deprivation. Furthermore, the
marker of sleep pressure SWA was reduced basally and after sleep loss in FB CREB
cKO animals. One possibility is that conditional CREB mutant mice did not reach the
same levels of sleep pressure as control animals due to the increased opportunity to
discharge SWA during the active period. Interestingly, SWA for FB CREB cKO animals
following enforced wakefulness are similar to SWA levels in control animals at lights on
during the baseline day. These findings are consistent with the hypothesis that reduced
SWA in CREB mutant mice stems from the inability to sustain wake during the active
period. Hence, our findings indicate that CREB is not directly involved in sleep
homeostasis and that CREB does not serve a restorative function during sleep.
Additionally, animals lacking CREB in forebrain neurons were unable to sustain
wakefulness but showed normal NREM and REM sleep architecture.
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This phenotype is similar to that of animals constitutively lacking two isoforms of CREB
(Graves et al., 2003b) and of animals lacking norepinephrine (Ouyang et al., 2004). One
possibility is that LC efferents to cerebral cortex promote wake by activating the CREB
signaling pathway. Consistent with this idea, increased pCREB in the cortex during
wakefulness requires LC inputs (Cirelli et al., 1996). Beta adrenergic receptors are
coupled to Gs and increase cAMP/PKA activity. Thus, increased cortical norepinephrine
during wakefulness could lead to increase pCREB via beta adrenergic signaling.
Consistent with this hypothesis, beta adrenergic agonist infusions into the basal
forebrain increase wakefulness and arousal (Berridge and Foote, 1996). The peptide
hypocretin/orexin is also thought to play a crucial role in the maintenance of
wakefulness(Saper, 2006; Adamantidis et al., 2007; Saper et al., 2011) and loss of
orexin signaling causes narcolepsy (Chemelli et al., 1999; Hara et al., 2001).
Interestingly, orexin selectively excites a subpopulation of neurons in the deep layer of
cortex that express the Gq coupled orexin-2 receptor (Bayer et al., 2004). Activation of
these cells could also lead to increased pCREB via intracellular calcium release. These
neurons also send broad projections to other cortical layers and their activation in turn
could result in broad cortical activity.

Consistent with previous reports, we found that deletion of CREB in the forebrain was
accompanied by compensatory increased expression of cAMP response element
modulator (CREM) (Hummler et al., 1994; Blendy et al., 1996; Rudolph et al., 1998;
Mantamadiotis et al., 2002; Parlato et al., 2006; Parlato et al., 2010). CREM is nearly
undetectable in the brain under normal conditions and this marked compensatory
increase has been shown to partly restore CREB function (Mantamadiotis et al., 2002).
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We were still able to detect changes in expression of CREB target genes Nr4a2 and
Gadd45b. Interestingly, activity-dependent expression of these transcripts requires
CREB activity in the hippocampus and striatum (Lemberger et al., 2008). Further studies
are needed to determine whether these changes in gene expression are functionally
relevant to the maintenance of wakefulness. This work suggests that the arousal system
efferents to the forebrain promote wakefulness via activation of CREB signaling. Further
studies are needed to refine where in the forebrain CREB is required for the
maintenance of wakefulness and which effector genes mediate arousal in these cells.
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Figure Legends

Figure 2.1. Forebrain CREB cKO animals show reduced CREB expression in
cortex.
A. Forebrain CREB cKO animals were generated using the cre/lox system. B. CREB
protein levels were quantified using optical density (shown in arbitrary units) in parietal
cortex of FB CREB cKO and wild-type littermates. * p<0.05. C and D.
Immunohistochemical stains using anti-CREB antibody (brown nuclei) of cortex for wildtype (C) and FB CREB cKO (D) mice. E and F. Sections from wild-type (E) and FB
CREB cKO (F) cortex tissue were imaged using fluorescent microscopy for CREB
(green) and propridium iodide (red).

Figure 2.2. Deletion of CREB in forebrain neurons reduces wakefulness. Total time
spent (min) in wake (A), NREM (B) or REM (C) sleep over 24 hours and during the light
and dark phase. Percent time in wake (D), NREM (E) and REM sleep (F) across 24 h
baseline period shown in 3 hour windows. Zeitgeber time (ZT) is represented on the x
axis. Lights come on at ZT 0. Black line represents the dark period. ‡ compares cre-only
to WT (p<0.05), * compares cKO to WT (p< 0.05).
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Figure 2.3. FB CREB cKO mice are unable to sustain wakefulness.
Number of bouts and average bout duration for wake (A and B, respectively), NREM (C
and D) and REM sleep (E and F) during the light and dark phase. Mean ± s.e.m. ‡
compares cre-only to WT (p<0.05), * compares cKO to WT (p< 0.05).

Figure 2.4. Forebrain deletion of CREB does not increase sleep homeostasis.
Animals were sleep deprived using gentle handling for 6 hours (ZT 0-6). Shown is
absolute change in total sleep (A), NREM (B) and REM sleep time (C) between the
recovery and baseline periods. Grey bar represents the SD period and black line
represents the dark period. D. SWA during baseline light period. E. SWA (expressed as
% of baseline) during recovery following 6 hours SD. Mean ± s.e.m., * p< 0.05.

Figure 2.5. Deletion of CREB in forebrain does not alter EEG spectral content.
EEG spectra were computed using FFT over 24 hours. Absolute and normalized power
is shown for wake (A & B, respectively), NREM (C & D) and REM (E &F) sleep. G.
Absolute Theta (6-10Hz) power during wake and REM sleep and NREM Delta (0.5-4Hz)
power are shown for FB CREB cKO and control animals. H. Normalized Theta (6-10Hz)
power during wake and REM sleep and NREM Delta (0.5-4Hz) power are shown for FB
CREB cKO and control animals. Mean ± s.e.m., ‡ compares cre-only to WT (p<0.05), *
compares cKO to WT (p< 0.05).
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Figure 2.6. LC CREB cKO show reduced CREB expression in LC neurons.
A. We used the cre/lox system to restrict deletion of CREB to noradrenergic neurons. B.
Percentage of noradrenergic (TH positive) neurons also labeled for CREB is reduced in
DBH CREB cKO animals. Mean ± s.e.m. * indicates p<0.05. C and D. Photomicrograph
of LC sections stained using an anti-TH antibody (brown cells) and anti-CREB antibody
(blue nuclei) for wild-type (C) and mutant (D) mice.

Figure 2.7. LC CREB cKO animals show normal levels of sleep/wake.
Total time spent (min) in wake (A), NREM (B) or REM (C) sleep over 24 hours and
during the light and dark phase. Percent time in wake (D), NREM (E) and REM sleep (F)
across 24 h baseline period shown in 3 hour windows. Zeitgeber time (ZT) is
represented on the x axis. Lights come on at ZT 0. Black line represents the dark period.
Mean ± s.e.m.

Figure 2.8. Deletion of CREB in LC does not disrupt sleep/wake architecture.
Number of bouts (A) and average bout duration for wake (B) for wake, NREM and REM
sleep. Mean ± s.e.m.
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Tables

Table 2.1. FB CREB cKO mice show reduced expression of CREB target genes in
the cortex during the active phase.

Tissue from cortex was collected at ZT 16 from FB CREB cKO and control mice (n=6).
Gene expression was measured using qPCR. Transcripts changed by deletion of CREB
are shown in bold. Mean ± s.e.m.
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Chapter 3. Aging in Mice Reduces the Ability to Sustain
Sleep/Wake States
Abstract
Study Objective: To determine the effects of aging on sleep/wake patterns in C57BL/6
mice using a novel statistical approach.
Measurements and Results: We used EEG/EMG recordings to quantify wake, nonrapid eye movement (NREM) and rapid-eye movement (REM) sleep. Aged animals
showed decreased wake during the active (dark) period and decreased REM sleep
during the rest (light) period. We used both conventional measures (i.e., bout number
and bout duration) and a novel statistical approach to examine the micro-architecture of
sleep and wake. The short (spike) and long (slab) components of the spike-and-slab
mixture model captures the distribution of bouts for each behavioral state in mice. Using
this novel analytical approach, we found that aged animals are less able to sustain long
episodes wakefulness or NREM sleep. Spectral analysis of EEG recordings revealed
that aging decreases low frequency slow wave activity, a marker of sleep quality that
responds to the duration and nature of prior wakefulness. Aging also slowed theta peak
frequency, a correlate of arousal and exploratory behavior.
Conclusions: Aged mice are less able to sustain sleep/wake states. The spike-and-slab
analytical approach enhanced our ability to detect age-related fragmentation of wake
and NREM sleep compared to conventional measures. EEG spectral profiles of aged
mice showed slowed theta peak frequency during wake and reduced low frequency
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SWA during NREM sleep suggesting that fragmentation of wake and NREM lead to
reductions in the quality of both of these states.
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Introduction
Life expectancy is on the rise worldwide. Within the US alone, it is estimated that 20% of
the population will be over the age of 65 years by 2030 (US Census estimate, 2010).
Normal aging produces sleep fragmentation and impairs the ability to sustain
wakefulness in humans (Dijk et al., 1989; Ehlers and Kupfer, 1989; Bliwise, 1993; Prinz,
1995; Landolt et al., 1996; Dijk et al., 2000), and rodents (Zepelin et al., 1972;
Eleftheriou et al., 1975; Rosenberg et al., 1979; Ingram et al., 1982; Van Gool and
Mirmiran, 1983; Welsh et al., 1986; Markowska et al., 1989; Stone et al., 1989;
Mendelson and Bergmann, 1999; Colas et al., 2005; Hasan et al., 2010; Naidoo et al.,
2011). Aging has also been shown to impact the amplitude and timing of circadian
biological rhythms (Ingram et al., 1982; Dijk et al., 2000; Weinert, 2000) and reduce the
homeostatic response to sleep loss (Shiromani et al., 2000; Hasan et al., 2010).
Previous studies suggest that alterations in neurotransmitter and receptor levels in brain
regions that regulate sleep/wake underlie these age-induced disruptions in sleep. Levels
of adenosine, a sleep promoting endogenous purine, are higher under baseline
conditions and following sleep loss in aged rats (Murillo-Rodriguez et al., 2004;
Mackiewicz et al., 2006), whereas adenosine A1 receptor binding is reduced with age
(Meerlo et al., 2004). In addition, aged animals show lower extracellular levels of the
wake promoting peptide hypocretin (orexin) and a reduction in the expression of
hypocretin receptors (Terao et al., 2002; Desarnaud et al., 2004). Orexinergic and
noradrenergic neurons in aged mice also show reduced activity during the active phase
(Naidoo et al., 2011). These age-related disruptions in signaling may underlie the
inability to maintain wakefulness and sleep, as well as the alterations of EEG spectral
profile that accompany normal aging. These two hallmarks of aging have been well
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characterized in humans (Dijk et al., 1989; Bliwise, 1993; Prinz, 1995; Landolt et al.,
1996) and rats (Zepelin et al., 1972; Rosenberg et al., 1979; Van Gool and Mirmiran,
1983; Markowska et al., 1989; Stone et al., 1989; Mendelson and Bergmann, 1999).
Interestingly, few studies have investigated the effects of normal aging on sleep in mice
(Eleftheriou et al., 1975; Welsh et al., 1986; Hasan et al., 2010; Naidoo et al., 2011) and
only one recent report (Hasan et al., 2010) examined the impact of aging on the spectral
profile of the EEG during sleep. To address changes in sleep with aging in mice to lay
the groundwork for future genetic studies, we studied differences in EEG spectral profile
and sleep architecture of young and aged C57BL/6 mice, one of the most commonly
used stains of mice in genetic and pharmacological studies. The unique architecture of
rodent sleep is characterized by the uneven distribution of short and long bouts in each
behavioral state (Lo et al., 2004; Blumberg et al., 2005; Joho et al., 2006; Behn et al.,
2007; Blumberg et al., 2007; Diniz Behn et al., 2008; Simasko and Mukherjee, 2009),
rendering average bout duration a poor descriptor of sleep/wake structure. Here, we
used a novel statistical approach (McShane et al., 2010) which faithfully models both
components of each behavioral state and permits the analysis of short and long bouts
simultaneously. We hypothesized that aging impairs the ability to sustain the longer
bouts of sleep and wake.

Methods
Animals and Surgery: 8 young (2-4 months) and 12 old (22-24 months) male
C57BL/6NIA mice were obtained from the National Institute of Aging mouse colony.
Animals were maintained on a 12 hour light/12 hour dark cycle with lights on (ZT 0) at
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7:00 am. Food and water were available ad libitum. All animal care and experiments
were approved by the Institutional Animal Care and Use Committee of the University of
Pennsylvania and conducted in accordance with the National Institute of Health
guidelines. Animals were implanted with EEG and EMG electrodes under isoflurane
anesthesia. Electrodes were held in place with dental cement (Ketac, 3M, St Paul, MN).
Electrodes consisted of Teflon coated wires (Cooner wires, Chatsworth, CA) soldered to
gold socket contacts (Plastics One, Roanoke, VA) and pushed into a 6-pin plastic plug
(363 plug, Plastics One). The contacts were cemented to the plug using dental cement.
Animals were connected to amplifiers using light-weight cables (363, Plastics One)
attached to a rotating commutator (SLC6, Plastics One). All recordings were obtained
using a parietal electrode (ML ±1.5mm, AP -4mm from bregma) referenced to an
electrode over the cerebellum (1.5 mm posterior of lambda). Mice were allowed to
recover from surgery for a minimum of 2 weeks. During the second week of recovery,
mice were acclimated to the cables and to the recording chambers.

EEG recordings and analysis: EEG/EMG signals were sampled at 256 Hertz (Hz) and
filtered at 0.5-30Hz and 1-100Hz, respectively with 12A5 amplifiers (Astro-Med, West
Warwick, RI). Data acquisition and visual scoring was performed using SleepSign
software (Kissei Comtec, INC, Japan). EEG/EMG recordings were scored in 4 second
epochs as wake, NREM, or REM by a trained experimenter blind to age. Epochs
containing movement artifacts were included in the state totals and architecture analysis,
but excluded from subsequent spectral analysis. Spectral analysis was performed using
a fast Fourier transform (FFT; 0.5-20Hz, 0.125Hz resolution). Wake EEG spectra were
computed during the dark phase, when wakefulness prevails. NREM and REM EEG
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spectra were calculated during the light phase, when mice are mostly asleep. NREM
slow wave activity (SWA) from ZT 0-8 was computed in 4 x 2-hour bins and SWA was
normalized to the last 4 hours of the light phase for each animal as previously described
(Franken et al., 2001).

Statistics: Student’s t-tests were used to compare wake, NREM and REM sleep levels
averaged over 24 hours. Multivariate analysis of variance (MANOVA) was used on the
proportion of time spent in each state during the light phase, the dark phase and during
the 8 x 3-hour bins across 24 hours, followed by Tukey studentized range tests to
compare the 2 age groups. The same procedure was applied to the number of bouts and
the average bout duration to compare age groups. In addition, a novel spike-and-slab
statistical model was used to examine sleep/wake microstructure. This mixture model,
where short bouts are represented by the spike and long bouts are captured by the slab
component was previously described in detail (McShane et al., 2010). Rather than
modeling the sequence of sleep states directly, this approach models the sequence of
unique states and their duration.

The unique states do not form a Markov chain,

because the durations are not exponentially distributed. A Kruskal-Wallis test revealed
that the duration of a bout is dependent upon the previous behavioral state (Table 1).
Thus, each state was fit using two separate models. Bout durations have been
traditionally modeled as gamma-distributed random variables. However, we found that
gamma assigns too little probability to short (spike) bouts and too much probability to
very long bouts (slabs, see Figure 3.3). The spike and slab model consists of a mixture
of a gamma distribution and point masses at k bouts for k=1, 2, …, 10. Standard model
selection methods including the Bayesian Information Criterion (BIC) and nonparametric
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Q-Q plots were used to determine whether the spike-and-slab formulation constitutes a
better fit than a single distribution. These tests revealed that the multi-parameter mixture
model is necessary and that the spike-and-slab distribution provides a far better fit than
any single two-parameter gamma distribution, as we previously reported in C57BL/6
mice (McShane et al., 2010).The spike and slab probability model was used to generate
a set of 12 descriptive summary statistics that can be further distilled into three key
parameters: 1) n, the number of bouts of the behavioral state, conditional on the
previous state 2) π, the proportion of spikes (short bouts) 3) μ, the average duration of
the slabs (long bouts).
Tukey studentized range tests were used to analyze raw EEG spectra for wake, NREM
and REM sleep. Student’s t-tests were used to analyze theta peak frequency for wake
and REM EEG spectra. NREM SWA during the 4 x 2-hour bins was analyzed using
repeated measures ANOVA followed by Tukey studentized range tests. Pearson’s
correlation was used to examine the relationship between time awake during the dark
phase and SWA during the first two hours of the subsequent light period.

Results
Aged mice have decreased wakefulness during the active period.
We used EEG/EMG recordings from young (2-4 months) and old (22-24 months) mice to
quantify wake, NREM and REM sleep. Aged animals showed decreased wakefulness
over 24 hours compared to young (Satterthwaite t-test, p=0.039, Figure 3.1A). In
comparison to young animals, aged mice spend more time awake during the light period
and less time awake during the dark phase, when mice are typically active
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(F(2,17)=10.84, p<0.001, Figure 3.1A). We also found that age affects the percentage of
time spent awake across the light/dark cycle (F(8,11)=7.4, p=0.0017, Figure 3.1B). We
used Tukey studentized range tests to examine the effect of age at 8 x 3 hour bins
across the 24-hour period (Figure 3.1B). These tests revealed that aged mice have more
wakefulness at the end of the light period and show decreased wake during most of the
dark phase (Figure 3.1B). Decreased wakefulness in aged mice over 24 hours was
accompanied by increased NREM sleep (t-test, p=0.031). This increase was most
obvious during the dark phase (F(2,17)=12.91, p<0.001, Figure 3.1C). Indeed, aged
mice showed increased NREM sleep at 3 of the 4 time points during the dark period
(F(8,11)=7.3, p=0.002, Figure 3.1D). REM sleep was overall unchanged when averaged
over 24 hours (t-test, p=0.17, Figure 3.1E). However, aged animals showed decreased
REM sleep during the light phase (F(2,17)=6.51, p=0.008, Figure 3.1E). When analyzed
in 3 hour bins, aged animals showed decreased REM sleep during most of the light
phase and increased REM sleep during one time point of the dark phase (F(8,11)=4.3,
p=0.014, Figure 3.1F).

Aged mice have reduced ability to sustain sleep/wake states.
Next, we examined sleep and wake architecture in young and aged mice using
conventional measures (i.e., number of bouts and average bout duration) for each state.
Aged mice had more bouts of wakefulness during the dark period compared to young
mice (F(2,17)=14.90, p=0.0002) and the average duration of wake bouts was shorter in
old mice during the dark phase (F(2,17)=18.07, p<0.0001, Figure 3.2A). Similarly, the
number of NREM bouts was higher in old mice during the dark phase (F(2,17)=12.31,
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p=0.0005) and the average NREM bout duration was lower in aged animals
(F(2,17)=9.7, p=0.0015, Figure 3.2B). The number of REM bouts was not affected by
age (F(2,17)=2.46, p=0.1151) and neither was the average duration of REM bouts
(F(2,17)= 2.14 , p=0.1484, Figure 3.2C). We also used a new spike-and-slab mixture
model to compare sleep/wake microstructure in young and aged animals (McShane et
al.). Typically, bout durations have been modeled as gamma-distributed random
variables. However, we found that gamma assigns too little probability to short bouts and
too much probability to very long bouts (Figure 3.3). The short (spike) and long (slab)
components of this model permit an improved fit of the distribution of bout durations in
mice (Figure 3.3). This was confirmed using BIC and Q-Q plots-based analyses. In
addition, we found that the duration of a bout in a given state is dependent upon the
previous state of the animals (Table 3.1). Therefore, each state was analyzed using two
models. For example, wake state was analyzed separately for wake bouts that were
preceded by NREM bouts and wake bouts that were preceded by REM sleep. The
number of NREM to wake episodes and wake to NREM bouts was higher in aged mice
(p=9.35 x 10-6 and p=6.43 x 10-5, respectively, Figure 3.4A). In addition, the average
duration of the slab was shorter for both wake and NREM sleep in aged mice (p=1.53 x
10-5 for NREM to wake and p= 1.67 x 10-3 for wake to NREM, Figure 3.4B). Thus, the
major difference between young and old mice is in the ability of old mice to sustain long
bouts of NREM sleep and wakefulness. The architecture of sleep/wake was only
disrupted in aged mice when animals were transitioning between wake and NREM
sleep. However, aging did not disrupt the architecture of REM sleep during the dark
phase (Table 3.2) or during the light phase (Table 3.3).
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Aged mice show reduced slow wave activity (SWA) and slower theta peak
frequency (TPF)
We used fast Fourier transform (FFT) of EEG recordings to examine the EEG spectral
profiles during each behavioral state for both age groups. Wake EEG spectra from both
young and old animals showed a peak in the theta frequency range but aged mice
showed reduced power in the theta range at frequencies between 8.5-9.625Hz (Tukey
Studentized range t-test, Figure 3.5A). Interestingly, age did not affect NREM sleep
spectra, which showed a characteristic peak in the delta (0.5-4Hz) frequency range in
both young and aged animals (Figure 3.5B). Aged mice showed higher power for a
small range of frequencies of the REM sleep spectra (2.375-2.625, Figure 3.5C). Theta
peak frequency (TPF) was determined by recording the frequency at which absolute
power was highest in the theta range (6-10Hz). Aging slowed TPF by about 1.5 Hz from
7.5±0.39Hz to 6.03±0.02Hz in the wake EEG spectra (Satterthwaite t-test, p=0.0072,
Figure 3.5D). Similarly, TPF was lower by about 0.34Hz in aged mice (6.63±0.05Hz)
compared to young (6.97±0.09Hz) in the REM spectra (t-test, p = 0.0026, Figure 3.5D).
The height of the peak in the theta range was not changed by aging during wake or REM
sleep. Slow wave activity (SWA), the spectral power of the EEG in the 0.5-4 Hz range
during NREM sleep is the best characterized marker of sleep intensity and changes in
response to sleep loss (Borbely et al., 1981; Borbely, 1982). Repeated measures
ANOVA revealed that SWA (0.5-4Hz) decreased over the course of the light phase
(F(3,54)=58.87, p<0.0001, Figure 3.5E), and that SWA (<4Hz) was not different between
young and aged mice (F(1,18)=0.54, p=0.47). These results suggest that sleep pressure
is discharged similarly during the rest period in young and aged mice. In addition, the
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time spent awake during the dark phase was not correlated with SWA (<4Hz) during the
first two hours of the subsequent light phase (Pearson’s, R2=0.14, p=0.54). SWA in
lower frequencies (0.5-1.5 Hz) is sensitive to changes in arousal and exploratory
behavior during the preceding active period (Cirelli et al., 2005; Qu et al., 2010). Thus,
changes in low frequency SWA (0.5-1.5Hz) is indicative of altered vigilance and
exploration during wakefulness. We found that low frequency SWA (0.5-1.5Hz)
decreases over the course of the light phase (F(3,54)=20.38, p<0.0001) and that low
frequency SWA is lower during the first two hours of the light phase in aged mice
compared to young animals (F(3,54)=6.57, p=0.0007, Figure 3.5F). Consistent with this
finding, time awake during the active period was positively correlated with low frequency
SWA during the first two hours of the subsequent light phase (Pearson’s, R2=0.49,
p=0.03), suggesting that the decrease in low frequency SWA is due in part to reduced
wake during the active period. One possibility is that aged animals have less opportunity
for exploration during the dark phase, which leads to reduced low frequency SWA during
the early part of the light phase.

Discussion
We confirmed and extended previous studies examining age-associated changes in
sleep/wake patterns with disturbances of sleep and wakefulness in aged mice. Studies
in the past 50 years have mapped the complex neural-circuitry that controls wakefulness
and sleep. The consensus based on these electrophysiological, genetic and lesion
experiments is that interactions between wake-producing and sleep-promoting networks
control transitions from one state to the next, while separate components of these
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networks stabilize each state (Parmentier et al., 2002; Mochizuki et al., 2004; Lu et al.,
2006; Takahashi et al., 2006, 2009; Qiu et al., 2010; Qu et al., 2010; Takahashi et al.,
2010; Saper et al., 2011). Consistent with this idea, behavioral states can be further
classified into short and long bouts in rodents (Lo et al., 2004; Blumberg et al., 2005;
Joho et al., 2006; Blumberg et al., 2007; Diniz Behn et al., 2008; Simasko and
Mukherjee, 2009). Historically, the conventional measures that are used to characterize
behavioral structure measure each of these components separately by computing the
number of transitions from one state to the next, the number of bouts for each state and
the average bout duration for wake, NREM and REM sleep (Parmentier et al., 2002;
Ouyang et al., 2004; Diniz Behn et al., 2010; Qu et al., 2010). However, these standard
metrics are correlated with one another and do not give independent views of each
behavioral state. Our improved understanding of the biological mechanisms governing
sleep/wake structure necessitated the creation of new models that better reflect and
capture the complexity of these processes. Some recent models of sleep/wake
dynamics have used a mixture of distributions to account for the uneven distribution of
bout lengths (Behn et al., 2007; Simasko and Mukherjee, 2009; Chu-Shore et al., 2010;
McShane et al., 2010). Our approach builds upon this literature, using a mixture of
distributions to simultaneously model short and long processes for each state transition.
Thus, this novel spike and slab formulation permits the quantification of all unique states,
number of bouts and bout duration for each sub-stage of wake, NREM and REM sleep.
We believe this model best reflects the complexity of sleep/wake dynamics in mice. This
analytical approach was previously used to confirm that sleep/wake architecture is under
genetic control (Franken et al., 1999; McShane et al., 2010). The current study shows for
the first time that spike-and-slab analysis can also be used to detect changes in
sleep/wake microstructure that accompany aging in mice. Our results suggest that aging
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disrupts the ability to sustain long bouts of wakefulness and NREM sleep without
affecting REM sleep architecture. We found that transitions from wake to NREM and
NREM to wake were uniquely altered by aging. These transitions are regulated by a
defined population of neurons, composed of two mutually inhibitory networks. The wakeproducing component includes the locus Coereleus (LC), Tuberomamillary nucleus
(TMN) and the ventrolateral periaqueductal gray (vPAG) (Takahashi et al., 2006, 2009;
Takahashi et al., 2010; Saper et al., 2011). Opposing these regions, the ventro-lateral
preoptic area (VLPO) promotes sleep (Lu et al., 2006) and inhibits the LC, TMN and
vPAG. Firing of noradrenergic cells of the LC precedes the onset of wakefulness out of
NREM sleep, but not out of REM sleep (Takahashi et al., 2010), suggesting that these
cells are critical to switching from NREM sleep to wake. Furthermore, LC neurons show
highest discharge rates during high vigilance (Takahashi et al., 2010), indicating a dual
role for both the induction and maintenance of wakefulness. Interestingly, aged animals
show decreased staining in noradrenergic neurons during the dark phase

for the

immediate early gene FOS, which has been used as a proxy for neuronal activity
(Naidoo et al., 2011). Reduced LC activity may contribute to the reductions in
wakefulness and the inability to sustain wake that we observed. In addition, the (VLPO)
shrinks with age (Gaus et al., 2002) and the number of VLPO cells is decreased in aged
animals (Senut et al., 1989). These neurons are particularly important for REM and
NREM sleep (Lu et al., 2000; Lu et al., 2006). Alterations in the activity patterns and
neurotransmitter release from LC and VLPO may contribute to more transitions between
these two states and reduce the inability of aged mice to maintain wakefulness and
NREM sleep. Reduced REM sleep may be caused by reduced activity in “REM-on cells”
of the VLPO during the light phase. Conversely, reduced activity in the LC and
orexinergic cells of the hypothalamus (Naidoo et al., 2011) in aged mice may lead to
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increased NREM sleep during the light phase. In light of recent findings regarding the
complex nature of the VLPO, further anatomical studies of the VLPO in aged animals
would be needed to address these questions. In addition, VLPO lesions do not
completely abolish sleep (Lu et al., 2000), suggesting that other unidentified brain
regions also contribute to sleep.

Theta activity during wakefulness is correlative of arousal, exploratory behavior, and
spatial navigation (Winson, 1978; Raghavachari et al., 2001; Wyble et al., 2004; Kunec
et al., 2005) and we found that aging slowed the peak in the theta component of the
wake EEG spectra. Intriguingly, spatial navigation and exploratory behavior are also
impaired by aging (Barnes, 1979; Gage et al., 1984; Markowska et al., 1989), which
raises the possibility of a connection between the disruptions of sleep/wake and the
cognitive impairments that occur with normal aging. We also measured SWA at low
frequencies (0.5-1.5Hz) because this frequency range is particularly sensitive to
changes in exploratory behavior and reductions in arousal (Cirelli et al., 2005; Qu et al.,
2010). Animals with lesions to the LC show reduced exploratory behavior and decreased
low frequency SWA during the early part of the light phase (Cirelli et al., 2005). This
manipulation also decreases markers of synaptic potentiation in the cortex during
wakefulness, suggesting that low frequency SWA is a marker of synaptic plasticity
during wakefulness. We found that decreased low frequency SWA (0.5-1.5 Hz) in aged
mice in the first two hours of the light phase is partly due to reduced wake time during
the preceding dark period. Because the correlation between wake time and SWA is fairly
weak, other factors are likely to contribute to lower SWA in aged mice. Alterations in the
continuity of wakefulness and reduced exploratory behavior in aged mice may in turn
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lead to reduced synaptic plasticity in the cerebral cortex during the active period.
Consistent with this hypothesis, theta activity and exploratory behavior during wake can
affect subsequent SWA during sleep (Huber et al., 2007), suggesting that slower TPF
and lower SWA (<1.5Hz) in aged animals may be linked. Taken together, our results
suggest that further studies examining the quality of wakefulness are needed to explore
the possibility that alterations in sleep/wake patterns are related to age-related cognitive
impairments.

The age-related changes in sleep/wake patterns that we observed are specific to
circadian time as previously reported (Welsh et al., 1986; Colas et al., 2005; Hasan et
al., 2010), indicating that changes in circadian rhythms caused aging are linked to
disruptions of sleep/wake states. Consistent with this hypothesis, the superchiasmatic
nucleus (SCN), which drives circadian rhythm in mammals, is directly affected by aging.
SCN cells show altered firing patterns or cease to fire rhythmically in aged mice (Nygard
et al., 2005). In addition, the rhythm of clock gene expression in the SCN of aged mice
shows reduced amplitude and rhythmic clock gene expression is either less stable or
phase advanced in aged animals (Weinert et al., 2001). Therefore, lower SCN outputs
during the dark phase may contribute to destabilization of wakefulness and NREM sleep.

In conclusion, the spike-and-slab approach, which simultaneously models short and long
processes for all state transitions, is useful for characterizing the underlying mechanisms
controlling both short and long bouts of each behavioral state. The major effect of age is
to limit the durations of sleep and wake that old mice can sustain during the active
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period. This provides a window into future investigations to the mechanisms involved in
the maintenance of wake and NREM sleep.
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Figure Legends
Figure 3.1. Aged mice show reduced wakefulness during dark phase and
decreased REM sleep during light phase. A. Total time (min) spent awake for young
and old mice over 24 hours (left) and during the light and dark period (right). B. Percent
time spent awake shown in 8 x 3-hour bins across light/dark cycle. Solid line represents
the dark period C. Aged mice show increased NREM sleep during the dark phase. Total
time spent in NREM sleep over 24 hours (left) and during the light and dark period
(right). D. Percent time spent in NREM in 3-hour bins. E. Old mice have decreased REM
sleep during the rest period. Total time spent in REM sleep for young and old mice over
24 hours (left) and during the light and dark period. F. Percent time spent in REM sleep
shown in 3-hour bins across light/dark cycle. Mean ± standard error of the mean
(s.e.m.), * p<0.05.

Figure 3.2. Aging causes fragmentation of wake and NREM sleep. A. Number of
bouts of wakefulness (left) and average wake bout duration (right) during the light and
dark phase. Aged mice show more bouts of wakefulness of shorter average duration
during the dark phase. B. Aged mice show fragmented NREM sleep during the dark
phase. Number of NREM bouts (left) and average NREM bout duration (right) during the
light and dark phase. C. Number of REM episodes (left) and average REM bout duration
during the light and dark period. Mean ± s.e.m., * p<0.05.
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Figure 3.3. Spike and Slab model shows improved fit over single distribution.
Distribution of NREM to Wake bout durations are shown for young and old mice during
the light (A) and dark period (B). The solid line represents the density of the spike and
slab model, and the dashed line represents the density of the traditional gamma model.
The gamma model assigns too little probability to short bouts and too much probability to
long bouts.

Figure 3.4. Aged mice are unable to sustain long bouts of wakefulness and NREM
sleep. A. Number of slabs (long bouts) during the dark phase for young and old mice
transitioning from NREM to wake (left) and from wake to NREM (right). Aged mice show
an increased number of slabs for both states. B. Average duration of slabs for mice
transitioning from NREM to wake (left) and wake to NREM (right). The duration of the
slabs for both transitions is reduced in aged animals. Mean ± s.e.m., ‡ p<0.00625
(Bonferroni correction).

Figure 3.5. Aging slows TPF and decreases SWA. A. Wake EEG spectra calculated
during the dark period for young and old mice. Aged animals show lower power in the
higher frequency range. B. EEG spectra for NREM sleep generated during the light
period for young and aged mice. Aging did not profoundly affect NREM spectral profile.
C. EEG spectra of REM sleep computed during the light phase for young and old mice.
D. Theta peak frequency (TPF) for wake and REM EEG during the dark and light phase,
respectively. TPF slowed with aging for both states. E. Slow wave activity (0.5-4Hz,
SWA) of NREM sleep for young and old mice expressed relative to the last 4 hours of
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the light period (=100%) for each animal. F. Low frequency (0.5-1.5) SWA of NREM
sleep young and old mice expressed relative to the last 4 hours of the light period
(=100%) for each animal. Mean ± s.e.m., gray bar and * indicate p<0.05.
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Tables:

Table 3.1. Bout duration in a given state is conditional on the previous state.

Wake and NREM bout durations were subdivided according to the previous state.
Shown are the medians (in 4 second epochs) for each group. Kruskal-Wallis tests were
used to compare bout durations for young and old mice during the light and dark period.
* indicates p-values that are significant after Bonferonni correction.
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Table 3.2. Spike-and-slab analysis, dark period

Transition

NREM to REM

NREM to Wake

REM to Wake

Wake to NREM

Quantity

Young

Old

p-value

n

25.88 ± 9.06

36.00 ± 16.10

0.125

μ

19.22 ± 4.20

20.93 ± 7.52

0.569

π

0.55 ± 0.16

0.59 ± 0.23

0.700

n

104.63 ± 25.06

213.67 ± 46.01 **

9.35x10

-6

μ

245.79 ± 48.58

137.39 ± 34.54 **

1.53x10

-5

π

0.79 ± 0.085

0.81 ± 0.04

0.574

n

25.88 ± 8.86

35.67 ± 16.12

0.136

μ

363.83 ± 363.224

93.55 ± 52.70

0.019

π

0.77 ± 0.07

0.80 ± 0.08

0.437

n

130.38 ± 31.86

249.08 ± 59.11 **

6.43x10

-5

μ

26.02 ± 5.07

18.89 ± 3.60 **

1.67x10

-3

π

0.27 ± 0.09

0.28 ± 0.16

0.794

Spike-and-slab analysis of each state during the dark period for young and old mice. n =
number of slabs, μ = average duration of slabs (in epochs), π = probability that the
animal is in a spike (short bout). Mean ± standard deviation. ** p<0.00625 (Bonferroni
correction).
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Table 3.3. Spike-and-slab analysis, light period
Transition

NREM to REM

NREM to Wake

REM to Wake

Wake to NREM

REM to NREM

Quantity

Young

Old

p-value

n

84.00 ± 11.28

77.00 ± 16.51

0.311

μ

21.74 ± 1.54

22.14 ± 3.06

0.734

π

0.45 ± 0.11

0.54 ± 0.11

0.074

n

205.38 ± 49.69

224.67 ± 49.65

0.406

μ

90.64 ± 21.43

84.91 ± 22.02

0.571

π

0.89 ± 0.03

0.83 ± 0.06

0.025

n

80.50 ± 10.39

73.00 ± 16.73

0.275

μ

66.29 ± 41.66

42.06 ± 17.29

0.086

π

0.88 ± 0.05

0.86 ± 0.10

0.533

N

284.88 ± 53.42

297.25 ± 58.10

0.636

μ

25.52 ± 4.28

23.73 ± 4.85

0.409

π

0.22 ± 0.09

0.26 ± 0.12

0.529

n

4.125 ± 1.126

4.167 ± 2.250

0.962

μ

12.346 ± 10.995

16.584 ± 18.730

0.572

π

0.250 ± 0.250

0.310 ± 0.358

0.690

Spike-and-slab analysis of each state during the light period for young and old mice.
n=number of slabs, μ = average duration of slabs (in epochs), π =probability that the
animal is in a spike. Mean ± standard deviation. No differences were significant during
the light period
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Chapter 4. Aging impairs hippocampus-dependent longterm memory for object location in mice
Abstract
The decline in cognitive function that accompanies normal aging has a negative
impact on the quality of life of the elderly and their families. Studies in humans
and rodents show that spatial navigation and other hippocampus-dependent
functions are particularly vulnerable to the deleterious effects of aging. However,
reduced motor activity and alterations in the stress response that accompany
normal aging can hinder the ability to study certain cognitive behaviors in aged
animals. In an attempt to circumvent these potential confounds, we used a
hippocampus-dependent object-place recognition task to show that long-term
spatial memory is impaired in aged mice. Aged animals performed similarly to
young adult mice on an object recognition task that does not rely on hippocampal
function.

Chapter in press as:
M.E. Wimmer, P. Hernandez, J. Blackwell, T. Abel, Aging impairs hippocampusdependent long-term for object location in mice, Neurobiology of Aging, Epub 2011.
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Introduction
Over the past 30 years, considerable effort has been devoted to the identification and
characterization of the neurological and molecular pathways that underlie age-related
cognitive impairments. Studies in humans and rodents show that the hippocampus is
particularly vulnerable to the effects of aging (Davis et al., 1993; Bach et al., 1999;
Gallagher et al., 2010), leading to impairments in episodic memory (Miller and
O'Callaghan, 2005; Park and Reuter-Lorenz, 2009) and spatial navigation (Barnes,
1979; Gage et al., 1984; Markowska et al., 1989). However, confounding factors such as
changes in motor activity and in the response to stress that accompany normal aging
can complicate the interpretation of studies using the Morris water maze and other
spatial navigation tasks (Sparkman and Johnson, 2008). The present studies focus on
object memory tasks, which are ideal to study both short- and long-term memory
formation because learning occurs within a single session (Baker and Kim, 2002; de
Lima et al., 2006; Oliveira et al., 2010). Furthermore, object-based tasks take advantage
of the innate tendency of mice to explore novel items in their environment, while inflicting
little stress on the animals (Save et al., 1992; Sharma et al., 2010), and the anatomical
substrates underlying object memory are well characterized (Ennaceur and Aggleton,
1997; Oliveira et al., 2010; Roozendaal et al., 2010).
Methods
Subjects
Young (2-4 months-old) and old (22-24 months-old) male C57BL/6NIA mice provided by
the National Institute of Aging were used in all experiments. Food and water were
provided ad libitum. Lights were maintained on a 12-12 light/dark cycle, and all
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experiments were performed in the light phase. Mice were singly housed a week before
training. Animals were handled in the experimental room for 1 minute per day for 3 days
prior to the first exposure to the training arena. All experiments were approved by the
Institutional Animal Care and Use Committee of the University of Pennsylvania and
conducted according to National Institutes of Health guidelines.
Object location memory task
Object location memory experiments were performed as described previously (Oliveira
et al., 2010) with minor modifications. On the day of training, mice were placed in the
training arena for a total of four 10-minute sessions with an inter-session interval of 3
minutes during which mice were returned to their home cages. The first session
consisted of a context habituation period without objects in the arena. During the next
three sessions, mice were placed in the training arena with two distinct objects. The
objects used were a glass bottle, and a metal tower (5’’H x 2’’W x 2’’L). The objects and
the arenas were wiped with 70% ethanol before each session. Either 3 minutes or 24
hours after training, mice were placed in the original training arena for 10 minutes with
one object displaced to a new location (displaced object, DO), while the other object was
not moved (non-displaced object, NDO). Exploration was recorded during training and
testing on a digital camera for subsequent scoring of time spent exploring objects.
Exploration of the objects was defined as the amount of time mice were oriented toward
an object with its nose within 1 cm of it, and was scored by an experimenter blind to age.
Object recognition memory task
Object recognition memory experiments were performed in the same training arenas and
using the same objects as previously described (Oliveira et al., 2010). Mice were pre73

exposed to the training context for 10 minutes on 3 consecutive days prior to object
training. 24 hours after the last context exposure, mice were placed in the training arena
with two identical objects and allowed to explore for 10 minutes. Twenty-four hours after
training, mice were placed in the original training arena for 10 minutes with one familiar
object and one novel object in the same locations used during training. Exploration was
measured and recorded as described above.
Data analysis
Percent preference in the object location experiment was calculated as time spent
exploring the DO relative to the total time spent exploring both objects (i.e., preference =
DO/(NDO+DO)). For object recognition experiments, percent preference was calculated
as time spent exploring the novel object relative to the total time exploring both objects
(i.e. novel/(familiar + novel)).
Repeated measures ANOVAs (RM-ANOVA) were used to compare age groups, during
training and retention test sessions for both tasks, with session as a within subject factor
and age as a between subject factor. Tukey post-hoc tests were used in the event of a
significant session x age interaction. p<0.05 was considered significant.
Results
We assessed hippocampal function and spatial memory formation in aged mice by using
a hippocampus-dependent object place recognition task (Save et al., 1992; Mumby et
al., 2002; Oliveira et al., 2010). Training consisted of three 10-minute exposures (3
minute inter-trial interval) to an arena that contained two distinct objects (Fig. 4.1A). Both
groups of animals spent an equal amount of time exploring what would ultimately be the
DO and NDO (RM-ANOVA, F(2,74)=0.18, p=0.83) where exploration of the objects
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gradually decreased over time (F(2,74)=33.98, p<0.001). Age had no effect on the time
spent exploring the objects (F(1,18)=2.29, p=0.14) and total exploration times for
sessions 1, 2 and 3 were 8.4 ± 1.0, 5.9 ± 1.3, 5.0 ± 0.6 seconds, for young mice, and
11.7 ± 0.8, 6.9 ± 0.6, 5.3 ± 0.7 seconds, for aged mice. Twenty-four hours after the last
session, young and old mice were re-introduced to the training arena with one of the two
objects displaced to a new location. The relative preference for the DO was calculated
as the percentage of object exploration time dedicated to this object. We compared the
preference for the DO for each age group during the last training session to the
preference during the 24 hour test. The preference for the DO increased during the test
for young mice, whereas old animals did not show a preference for either object during
either sessions (session x age interaction: F(1,18)=5.15, p=0.036). Aged mice showed
lower preference for the DO than young animals (post-hoc Tukey tests , p<0.05) only
during the 24 hour retention test session, suggesting that aged mice have impaired
spatial memory (Fig. 4.1 B). Next, we assessed short term memory, using the same
training protocol in a different cohort of young and old mice. RM-ANOVA revealed that
time spent exploring the objects decreased over the course of the three training sessions
(F(2,78)=20.70, p<0.001) and the animals spent equal time exploring what would
ultimately become the DO and NDO (F(2,78)=0.07, p=0.93), with no effect of age
(F(2,38)=0.46, p=0.64). Three minutes after the last training session, the animals were
returned to the training arena with one object displaced to a novel location. In this case,
young and aged animals showed a preference for the DO (session: F(1,19)=20.49,
p<0.001; session x age: F(1,19)=0.15, p=0.70), suggesting that acquisition of spatial
memory was not affected by aging (Fig. 4.1C). Taken together, these results indicate
that hippocampal function declines with age, causing impairments in the consolidation of
long-term spatial memory.
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To address whether these deficits are specific to the hippocampus and spatial memory,
we assessed object recognition in young and old mice. We and others have shown that
object recognition becomes independent of the hippocampus if the task is conducted
with limited spatial cues (Forwood et al., 2005) or if the animals are familiarized to the
context before training (Oliveira et al., 2010). We removed spatial cues from the walls
and the animals were familiarized to the training arena for three consecutive days prior
to training. On the fourth day, animals were placed into the same training arena
containing 2 identical objects and allowed to explore for ten minutes. Twenty-four hours
later, mice were re-introduced to the context containing one familiar object and one
novel object (Fig. 4.2A). The relative preference for the novel object was calculated as
the percentage of object exploration time dedicated to this object. Both young and old
mice showed a preference for the novel object 24 hours after training (session:
F(1,29)=25.67, p<0.001; session x age: F(1,29)=0.21, p=0.65), suggesting that object
recognition is unaffected by aging (Fig. 4.2B).
Discussion
Using an object-place recognition task, we found that spatial memory consolidation is
impaired in aged mice. Age-related cognitive decline can be difficult to characterize due
to changes in motor activity (Gage et al., 1984; Markowska, 1999) and stress-related
physiology and behaviors (Sparkman and Johnson, 2008) that can alter performance in
spatial tasks (e.g., Barnes and Morris water maze). Object-based tasks are
advantageous because they are not physically demanding and they induce little stress.
However, the requirement of the hippocampus for object-based memory (Forwood et al.,
2005; Oliveira et al., 2010) and retention length (Roozendaal et al., 2010) are known to
vary with training protocol. For example, aging was found to impair both object-place and
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novel-object recognition tasks when using relatively short training sessions (Murai et al.,
2007; Burke et al., 2010). Here we used two training protocols that produce robust longterm memory and allow for the dissociation of hippocampal involvement. Extended preexposure to the training context is known to reduce the role of the hippocampus in the
novel object recognition task (Forwood et al., 2005; Oliveira et al., 2010). Thus, we
provide a more direct examination of the effects of aging on spatial memory formation
and consolidation.
Previous attempts to rescue age-induced memory deficits have involved systemic
injections of memory-enhancing compounds, (Davis et al., 1993; Markowska et al.,
1994; Bach et al., 1999; de Lima et al., 2005; de Lima et al., 2008; Rech et al.) often
administered prior to training. A recent study found that injections of histone deacetylase
(HDAC) inhibitors into the hippocampus prior to fear conditioning can rescue age-related
contextual fear memory impairments (Peleg et al., 2010). Our findings raise the
interesting possibility of enhancing hippocampal function immediately after training in
order to ameliorate age-induced spatial memory impairments.
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Figure Legends
Figure 4.1. Aged mice have impaired long-term memory for object location. a)
Diagram illustrating the experimental design for object place recognition. Animals were
exposed to the context once for 10 minutes followed by three 10 minute training
sessions with a 3 minute inter-trial interval. Testing occurred either 24 hours or 3
minutes after the last training session by moving one of the objects to a new location. b)
Bar graphs showing the percent preference for the displaced object (DO) at 24 hours for
young (n=10) and aged (n=10) animals. c) Graphs showing the percent preference for
the DO at 3 minutes for young (n=10) and aged (n=11) mice. Dotted line denotes 50%
(chance) preference. * p<0.05.

Figure 4.2. Aged mice show normal object recognition. a) Diagram illustrating the
experimental design for object recognition. Animals were familiarized to the training
context 10 minutes per day for 3 days prior to training. On the 4th day, 2 identical objects
were introduced for 10 minutes. 24 hours later the animals were tested for object
recognition by replacing one of the familiar objects with a novel object. b) Bar graphs
showing the percent preference for the novel object in young (n=16) and old (n=15)
animals. Dotted line denotes 50% (chance) preference. * p<0.05.
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Chapter 5. Conclusions
The studies described in this thesis have explored the molecular mechanisms that
regulate sleep/wake and memory formation in mice and how these processes are
altered by aging. In this chapter, I will review our primary findings, discuss some the
questions that our findings have raised and describe future avenues of research for this
work.

CREB signaling is essential for the maintenance of wakefulness.
In Chapter 2, we show that deletion of CREB in forebrain neurons reduces the ability to
sustain wakefulness. The cerebral cortex is the common output of wake promoting brain
regions such as the locus Coereleus (LC), the orexinergic neurons of the lateral
hypothalamus and the dorsal Raphe nucleus (DR) (Saper, 2006; Datta and Maclean,
2007). Interestingly, studies in rats show that pCREB levels increase in the cortex during
wakefulness and decrease during sleep (Cirelli et al., 1996; Cirelli and Tononi, 2000).
Our results suggest that this increase is functionally relevant to the maintenance of
wakefulness. Consistent with this interpretation, constitutive deletion of 2 isoforms of
CREB reduces wakefulness and wake-related cortical arousal (Graves et al., 2003b). It
will be important to extend our studies and define the area(s) of the forebrain and the
neuronal cells where CREB is required to sustain wakefulness. Our manipulations also
caused deletion of CREB in the striatum, the hippocampus and the amygdala. However,
the cholinergic basal forebrain, a known wake-promoting area, was spared in our
experiments. Cortex-specific cre expressing lines, such as the Emx-driven Cre line
(stock number 005628) available from Jackson labs, could be used to refine our findings.
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Our laboratory has also recently acquired a mouse line where expression of Cre
recombinase is restricted to layer VI of the cortex. It will be of interest to examine
whether deletion of CREB from layer VI affects wakefulness because neurons
expressing orexin-2 receptors in layer VIb are uniquely activated by the wake promoting
peptide orexin (Bayer et al., 2004).

Expression of Cre recombinase can be detected as early as E18.5 with high levels of
expression at P5 in the forebrain Cre line that we used in Chapter 2 (Dragatsis and
Zeitlin, 2000). Thus, we cannot exclude the possibility that developmental effects
contribute to the phenotype that we observed. Viral approaches represent a promising
avenue to address this concern. One potential limitation is the magnitude of the spread
of infection, which could be problematic when targeting large areas such as the cortex.
WPRE-mediated enhancement in viral infection (Klein et al., 2006), combined with
multiple injection sites could be used to ensure that a large part of the cortex is covered.
Another concern is that high levels of Cre expression can produce observable
phenotypes and cause cellular toxicity (Forni et al., 2006). Thus, further experiments are
needed to exclude the possibility that high levels of Cre expression in the forebrain can
alter sleep/wake states. To address this potential pitfall, additional animals carrying only
the Cre transgene should be characterized for sleep/wake patterns.

Deletion of CREB is accompanied by compensatory increased expression of cAMP
response element modulator (CREM), another member of the same family of
transcription factors (Hummler et al., 1994; Blendy et al., 1996; Rudolph et al., 1998;
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Mantamadiotis et al., 2002; Parlato et al., 2006; Parlato et al., 2010). CREM is nearly
undetectable in the brain under normal conditions and in the context of development and
neurodegeneration, one allele of CREM is sufficient to restore some CREB function
(Mantamadiotis et al., 2002). Thus, it would be of interest to explore the role of CREM
upregulation in our experiments. One way to address this question would be to raise
conditional CREB mutant animals on CREM deficient backgrounds. The prediction
would be that CREM upregulation ameliorates CREB signaling and improve the
behavioral phenotype that we observed, based on previous findings (Lemberger et al.,
2008; Parlato et al., 2010).

The most studied and best characterized CREB signaling cascade requires
phosphorylation of CREB and subsequent recruitment of co-activators, such as CREB
binding protein (CBP) and p300 (Kwok et al., 1994; Lundblad et al., 1995; Mayr and
Montminy, 2001; Johannessen et al., 2004). However, CREB-mediated transcription is
also regulated in a phosphorylation-independent fashion via interaction with CREBregulated transcription coactivators (CRTCs) (Conkright et al., 2003; Takemori et al.,
2007; Xu et al., 2007). Furthermore, CRTC1, one of the three CRTC isoforms, is highly
expressed in prefrontal cortex (Conkright et al., 2003), a region known to be important
for high vigilance and arousal (Gompf et al., 2011). Because genetic deletion of CREB
affects both phosphorylation dependent and independent pathways, additional studies
are needed to determine which signaling cascade(s) is (are) required for the regulation
of sleep/wake. CRTC mutants and animals carrying point mutations preventing the
interactions between CREB and its co-activators represent promising strategies to tease
out which activation pathway(s) are involved in the maintenance of wakefulness.
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CREB-mediated gene transcription is exceedingly complex, and several distinct
pathways are involved in translating external stimuli into alterations in the expression of
CREB target genes. Much research has focused on identifying the CREB
“transcriptome” (i.e. all of the genes regulated by CREB). Although CREB can bind to a
few thousand gene promoters containing the consensus cAMP response elements
(CRE) site, it is still unclear what fraction of these genes is functionally regulated by this
interaction (Zhang et al., 2005). Furthermore, not all CRE sites are functional CREB
targets, presumably because some of these are not be accessible within the chromatin.
Importantly, the CREB transcriptome differs dramatically from cell type to cell type (ChaMolstad et al., 2004), indicating that CREB controls partially distinct subsets of genes
within each brain region. Some in vivo work has focused on CREB target gene
expression in the hippocampus or in the striatum (Bozon et al., 2003; Lemberger et al.,
2008) and their influence on behavior. However, few studies have examined 1) which
CREB target genes are expressed in brain regions involved in the regulation of sleep
and wake such as the cortex or 2) the functional relevance of the observed changes in
cortical gene expression across sleep/wake (Cirelli et al., 1996; Cirelli and Tononi,
2000). The conditional CREB mutant mice described in Chapter 2 would be a useful tool
to begin addressing these questions. One major hurdle is the heterogeneity of cortical
tissue, which limits our ability to detect small changes in gene expression using qPCRbased approaches. In situ hybridization measurements could be used to address this
issue, although these measurements can be technically difficult and tend to be less
quantitative than qPCR.
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What are the molecular mechanisms underlying age-related disruptions of
sleep/wake?
Phosphorylation of CREB at serine 133 is one of the key events regulating CREBmediated transcription (Figure 1.2). Studies show that both calcium homeostasis and
calcium buffering (Foster et al., 2001; Toescu, 2007; Toescu and Vreugdenhil, 2010) are
altered by aging, which could affect activity of calcium-calmodulin kinases (Xu et al.,
2010) and phosphorylation of CREB. Much of this work has focused on regions of the
brain that are required for memory formation and little is known about how activity of
these signaling cascades is altered by aging. In the cortex, PKA activity is lower in aged
rats (Karege et al., 2001b) and our pilot studies suggest that pCREB levels are lower in
aged mice compared to young adult animals (data not shown). In Chapter 2, we showed
that CREB signaling in the forebrain is essential to the maintenance of wakefulness. In
Chapter 3, we found that aged animals are unable to sustain long periods of
wakefulness, similarly to mice lacking CREB in the forebrain. These observations raise
several questions: 1) is CREB signaling reduced in the forebrain of aged mice? Our pilot
studies indicate that pCREB levels are lower in the cortex of aged mice compared to
young. 2) can age-induced fragmentation of wakefulness be rescued by increasing
CREB signaling in the brain of aged mice? Several genetic tools are available to address
this possibility. Our laboratory has developed viral approaches to express Gs coupled
drosophila octopamine receptors, which could be use to increase cAMP signaling
acutely in discrete areas of the brain. This construct could be injected in the cortex of
aged mice to test the ability of increased cAMP signaling in rescuing long bouts of
wakefulness in aged mice. Dr. Satoshi Kida has also developed a line of transgenic mice
over-expressing CaMKIV (CaMKIV-OE), which increases pCREB levels (Fukushima et
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al., 2008). One future direction would be to measure sleep/wake in young and aged
CaMKIV-OE and control animals. Our prediction is that CaMKIV-OE animals will be
resistant to the deleterious effects of aging on the ability to sustain wakefulness. 3) Does
deletion of CREB in forebrain neurons occlude age-related fragmentation of
wakefulness? Measuring sleep/wake in aged FB CREB cKO and control animals would
address whether decreased CREB signaling is responsible for age-induced disruptions
in sleep/wake.

Molecular mechanisms of age-related cognitive decline.
CREB-mediated transcription can be induced by several pathways including the
cAMP/PKA and the calcium-CaMK kinase cascades (Figure 1.2). Interestingly, aging
alters cAMP/PKA activity, calcium and CREB signaling in the brain (Zhang et al., 1996;
Bach et al., 1999; Foster et al., 2001; Karege et al., 2001a; Karege et al., 2001b; Ramos
et al., 2003; Brightwell et al., 2004; Hattiangady et al., 2005; Kudo et al., 2005; Monti et
al., 2005; Ramos et al., 2006; Countryman and Gold, 2007; Fukushima et al., 2008;
Loerch et al., 2008; Porte et al., 2008; Wang et al., 2010; Xu et al., 2010). pCREB levels
are lower in the hippocampus and in the amygdala of wild-type aged animals (Brightwell
et al., 2004; Kudo et al., 2005; Countryman and Gold, 2007; Porte et al., 2008) and in a
mouse model of accelerated aging (Tomobe et al., 2007). Aging also causes changes in
calcium homeostasis and calcium buffering (Foster et al., 2001; Toescu, 2007; Toescu
and Vreugdenhil, 2010), which can lead to reduced CaMKIV activation (Qu et al., 2010).
In addition, CaMKIV expression (Loerch et al., 2008) and protein levels (Fukushima et
al., 2008) are reduced by aging. Pharmacological studies also indicate that cAMP
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signaling is altered by aging (Bach et al., 1999; Mouravlev et al., 2006; Ramos et al.,
2006; Wang et al., 2010). However, cAMP levels in the aged brain have not been
directly assayed to our knowledge, perhaps in part due to the technical difficulty of these
experiments. Our pilot measurements indicate that baseline cAMP levels are lower in the
hippocampus of aged (22-24 months) mice compared to young (2-4 months old, data not
shown). Consistent with these observations, PKA activity is reduced in the hippocampus
and in the cortex of aged rats (Karege et al., 2001a; Karege et al., 2001b). A prominent
hypothesis in the literature is that altered activity of CREB activating cascades and
reduced CREB signaling in the hippocampus and in the amygdala underlie age-related
decline in cognition. Consistent with this hypothesis, CREB deficient mice seem to be
more sensitive to age-related cognitive impairments (Hebda-Bauer et al., 2007),
whereas boosting CaMKIV expression and p-CREB levels in the hippocampus of aged
animals can rescue cognitive deficits (Fukushima et al., 2008). Experiments described in
Chapter 4 have laid the groundwork for further exploration of the molecular
underpinnings of age-related cognitive decline, by identifying where and when altered
signaling is likely to impair memory formation. Our results indicate that signaling in aged
animals is likely to be affected in the hippocampus during memory consolidation. Studies
suggest that consolidation of object-related memories occurs during the 4-6 hours
following training (de Lima et al., 2006; Oliveira et al., 2010). Thus, future studies should
focus on measuring cAMP, pCREB and PKA activity in the hippocampus in the hours
following training on object tasks. Intra-hippocampal pharmacological manipulations
aimed at rescuing age-induced spatial memory deficits would address the functional
relevance of the changes in CREB signaling in the brain of aged mice. An alternative
approach is the use of light-activated adenylyl cyclase (Schroder-Lang et al., 2007) or
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transgenic approaches using the Gs-coupled drosophila octopamine receptors in the
hippocampus to temporarily increase cAMP signaling in the hippocampus.

Sleep deterioration and impaired memory formation with aging.
The function of sleep remains one of science’s unanswered questions and a topic of
ongoing debate. What is clear is that sleep can improve memory formation (Marshall et
al., 2004; Walker and Stickgold, 2006) and that sleep deprivation negatively impacts
cognition (Graves et al., 2003a; Palchykova et al., 2006; Halassa et al., 2009;
Palchykova et al., 2009; Hagewoud, 2010; Hagewoud et al., 2010; Florian et al., 2011).
A recent study shows that the integrity (i.e. the architecture) of sleep is important for
memory consolidation (Rolls et al., 2011). In Chapters 3 and 4, we found that aging
affects both sleep/wake and memory consolidation. One question that has proven
difficult to address is the relationship between deficits in memory formation and sleep
disturbances in the elderly. The rescue experiments described above could be one way
to tease out whether these two phenomena are linked.
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